Hubbry Logo
PeriodontologyPeriodontologyMain
Open search
Periodontology
Community hub
Periodontology
logo
7 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Periodontology
Periodontology
from Wikipedia

Periodontist
Occupation
Occupation type
Specialty
Activity sectors
Dentistry
Description
Education required
Dental degree
Fields of
employment
Hospitals, private practices

Periodontology or periodontics (from Ancient Greek περί, perí – 'around'; and ὀδούς, odoús – 'tooth', genitive ὀδόντος, odóntos) is the specialty of dentistry that studies supporting structures of teeth, as well as diseases and conditions that affect them. The supporting tissues are known as the periodontium, which includes the gingiva (gums), alveolar bone, cementum, and the periodontal ligament. A periodontist is a dentist that specializes in the prevention, diagnosis and treatment of periodontal disease and in the placement of dental implants.[1]

The periodontium

[edit]
A diagram of the periodontium. A. Enamel B. Dentine C. Alveolar bone D. Oral epithelium E. Attached gingiva F. Gingival margin G. Gingival sulcus H. Junctional epithelium I. Alveolar crest fibres of periodontal ligament [PDL] J. Horizontal fibres of PDL K. Oblique fibres of PDL

The term periodontium is used to describe the group of structures that directly surround, support and protect the teeth. The periodontium is composed largely of the gingival tissue and the supporting bone.[2]

Gingivae

[edit]

Normal gingiva may range in color from light coral pink to heavily pigmented. The soft tissues and connective fibres that cover and protect the underlying cementum, periodontal ligament and alveolar bone are known as the gingivae. The gingivae are categorized into three anatomical groups: the free, attached and the interdental gingiva. Each of the gingival groups are considered biologically different; however, they are all specifically designed to help protect against mechanical and bacterial destruction.[3][page needed]

Free gingiva

[edit]

The tissues that sit above the alveolar bone crest are considered the free gingiva. In healthy periodontium, the gingival margin is the fibrous tissue that encompasses the cemento-enamel junction, a line around the circumference of the tooth where the enamel surface of the crown meets the outer cementum layer of the root. A natural space called the gingival sulcus lies apically to the gingival margin, between the tooth and the free gingiva. A non-diseased, healthy gingival sulcus is typically 0.5-3mm in depth, however, this measurement can increase in the presence of periodontal disease. The gingival sulcus is lined by a non-keratinised layer called the oral sulcular epithelium; it begins at the gingival margin and ends at the base of the sulcus where the junctional epithelium and attached gingiva begins.[4]

Attached gingiva

[edit]

The junctional epithelium is a collar-like band that lies at the base of the gingival sulcus and surrounds the tooth; it demarcates the areas of separation between the free and attached gingiva. The junctional epithelium provides a specialized protective barrier to microorganisms residing around the gingival sulcus.[4] Collagen fibres bind the attached gingiva tightly to the underlying periodontium including the cementum and alveolar bone and vary in length and width,[4] depending on the location in the oral cavity and on the individual.[5][page needed][6][page needed] The attached gingiva lies between the free gingival line or groove and the mucogingival junction. The attached gingiva dissipates functional and masticatory stresses placed on the gingival tissues during common activities such as mastication, tooth brushing and speaking.[7]: 80–81  In health it is typically pale pink or coral pink in colour and may present with surface stippling or racial pigmentation.[7][page needed]

Interdental gingiva

[edit]

The interdental gingiva takes up the space beneath a tooth contact point, between two adjacent teeth. It is normally triangular or pyramidal in shape and is formed by two interdental papillae (lingual and facial).[4][5] The middle or centre part of the interdental papilla is made up of attached gingiva, whereas the borders and tip are formed by the free gingiva. The central point between the interdental papillae is called the col. It is a valley-like or concave depression that lies directly beneath the contact point, between the facial and lingual papilla.[6] However, the col may be absent if there is gingival recession or if the teeth are not contacting. The main purpose of the interdental gingiva is to prevent food impaction during routine mastication.[7][page needed]

Alveolar mucosa

[edit]

This area of tissue is non-keratinized and is located beyond the mucogingival junction. It is less firmly attached and is redder than attached gingiva. It provides for the movement of cheek and lips.[8]

Periodontal ligament

[edit]

The periodontal ligament is the connective tissue that joins the outer layer of the tooth root, being the cementum, to the surrounding alveolar bone. It is composed of several complex fibre groups that run in different directions and which insert into the cementum and bone via Sharpey's fibres.[4] The periodontal ligament is composed mostly of collagen fibres, however it also houses blood vessels and nerves within loose connective tissue.[6] Mechanical loads that are placed on the teeth during mastication and other external forces are absorbed by the periodontal ligament, which therefore protects the teeth within their sockets.[7][page needed]

Alveolar bone

[edit]

In periodontal health, the alveolar bone surrounds the teeth and forms the bony socket that supports each tooth. The buccal and lingual plates and lining of the sockets are composed of thin, yet dense compact or cortical bone.[3] Within the cortical plates and dental sockets lies cancellous bone, a spongy or trabecular-type bone which is less dense than compact bone.[6] The anatomic landmarks of the alveolar process includes the lamina dura, the alveolar crest, and the periodontal ligament space.[9]

Cementum

[edit]

Cementum is the outer layer of the tooth root; it overlies the dentine layer of the tooth and provides attachment for the collagen fibres of the periodontal ligament. It also protects the dentine and provides a seal for the otherwise exposed ends of the dentinal tubules. It is not as hard as enamel or dentine and is typically a light yellow colour.[7][page needed]

Gingival diseases

[edit]

Gingivitis is a common condition that affects the gingiva or mucosal tissues that surround the teeth. The condition is a form of periodontal disease; however, it is the least devastating, in that it does not involve irreversible damage or changes to the periodontium (gingiva, periodontal ligament, cementum or alveolar bone). It is commonly detected by patients when gingival bleeding occurs spontaneously during brushing or eating. It is also characterized by generalized inflammation, swelling, and redness of the mucosal tissues. Gingivitis is typically painless and is most commonly a result of plaque biofilm accumulation, in association with reduced or poor oral hygiene. Other factors may increase a person's risk of gingivitis, including but not limited to systemic conditions such as uncontrolled diabetes mellitus and some medications. The signs and symptoms of gingivitis can be reversed through improved oral hygiene measures and increased plaque disruption. If left untreated, gingivitis has the potential to progress to periodontitis and other related diseases that are more detrimental to periodontal and general health.[10]

Periodontal diseases

[edit]

Periodontal disease encompasses a number of diseases of the periodontal tissues that result in attachment loss and destruction of alveolar bone.[11]

Periodontal diseases take on many different forms but are usually a result of a coalescence of bacterial plaque biofilm accumulation of the red complex bacteria (e.g. P. gingivalis, T. forsythia, and T. denticola) of the gingiva and teeth, combined with host immuno-inflammatory mechanisms and other risk factors that can lead to destruction of the supporting bone around natural teeth. Untreated, these diseases can lead to alveolar bone loss and tooth loss. As of 2013, periodontal disease accounted for 70.8% of teeth lost in patients with the disease in South Korea.[12] Periodontal disease is the second most common cause of tooth loss (second to dental caries) in Scotland.[13] Twice-daily brushing and flossing are a way to help prevent periodontal diseases.[14]

Healthy gingiva can be described as stippled, pale or coral pink in Caucasian people, with various degrees of pigmentation in other races.[15] The gingival margin is located at the cemento-enamel junction without the presence of pathology. The gingival pocket between the tooth and the gingival should be no deeper than 1–3mm to be considered healthy. There is also the absence of bleeding on gentle probing.[11]

Periodontal diseases can be caused by a variety of factors, the most prominent being dental plaque. Dental plaque forms a bacterial biofilm on the tooth surface; if not adequately removed from the tooth surface in close proximity to the gingiva, a host-microbial interaction gets underway. This results in the imbalance between host and bacterial factors which can in turn result in a change from health to disease. Other local or systemic factors can result in or further progress the manifestation of periodontal disease. Other factors can include age, socio-economic status, oral hygiene education and diet. Systemic factors may include uncontrolled diabetes or tobacco smoking.[16]

Signs and symptoms of periodontal disease: bleeding gums, gingival recession, halitosis (bad breath), mobile teeth, ill-fitting dentures and buildup of plaque and calculus.[17]

Individual risk factors include: gender, smoking and alcohol consumption, diabetes, obesity and metabolic syndrome, osteoporosis and Vitamin D conditions, stress and genetic factors.[18]

2018 AAP/EFP classification of periodontal and peri-implant diseases and conditions

[edit]

In 2017, the American Academy of Periodontology (AAP) and the European Federation of Periodontology (EFP) together collaborated to revise and adopt a new classification system for periodontal conditions to aid in a more personalized approach to patient care. In 2018 they released an updated classification system which includes a multi-dimensional staging and grading system for periodontitis classification, a recategorization of various forms of periodontitis, and the inaugural classification for peri-implant diseases and conditions.[19]

Periodontal health, gingivitis, and gingival diseases and conditions

[edit]
Healthy gingiva
Gingivitis after treatment

The 2018 Disease Classification for periodontal health, gingivitis, and gingival diseases and conditions are outlined in detail below:[7]: 81 

  1. Periodontal health and gingival health
    1. Clinical gingival health on an intact periodontium
    2. Clinical gingival health on a reduced periodontium
      • Stable periodontitis patient
      • Non-periodontitis patient
  2. Gingivitis—dental biofilm-induced
    1. Associated with dental biofilm alone
    2. Medicated by systemic or local risk factors
    3. Drug-influenced gingival enlargement
  3. Gingival diseases—nondental biofilm-induced
    1. Genetic or developmental disorders
    2. Specific infections
    3. Inflammatory and immune conditions
    4. Reactive processes
    5. Neoplasms
    6. Endocrine, nutritional, and metabolic diseases
    7. Traumatic lesions
    8. Gingival pigmentation

Disease classification for the three major forms of periodontitis

[edit]
Periodontal recession on maxillary central incisors
Bone loss in periapical radiograph

The 2018 Disease Classification of Periodontal Diseases and Conditions breaks down the category of periodontitis into three forms and each of these forms are further broken down into two or more subcategories.[7][page needed]

  1. Necrotizing periodontal diseases
    1. Necrotizing gingivitis
    2. Necrotizing periodontitis
    3. Necrotizing stomatitis
  2. Periodontitis as manifestation of systemic diseases – Classification of these conditions should be based on the primary systemic disease according to the International Statistical Classification of Diseases and Related Health Problems (ICD) codes
  3. Periodontitis
    1. Stages: Based on severity[a] and complexity of management[b]
      • Stage I: Initial periodontitis
      • Stage II: Moderate periodontitis
      • Stage III: Severe periodontitis with potential for additional tooth loss
      • Stage IV: Severe periodontitis with potential for loss of the dentition
    2. Extent and distribution:[c] Localized, generalized; molar-incisor distribution
    3. Grades: Evidence or risk of rapid progression,[d] anticipated treatment response[e]
      • Grade A: Slow rate of disease progression
      • Grade B: Moderate rate of disease progression
      • Grade C: Rapid rate of disease progression

Other conditions affecting the periodontium

[edit]
Abscessed tooth periapical radiograph

The 2018 Disease Classification of Periodontal Disease and Conditions contains a category for other conditions that may have an effect upon the health of the periodontium.[7][page needed]

  1. Systemic diseases or conditions affecting the periodontal supporting tissues
  2. Other periodontal conditions
    1. Periodontal abscesses
    2. Endodontic periodontal lesions
  3. Mucogingival deformities and conditions around teeth
    1. Gingival phenotype
    2. Gingival/soft tissue recession
    3. Lack of gingiva
    4. Decreased vestibular depth
    5. Aberrant frenum or muscle position
    6. Gingival excess
    7. Abnormal colour
    8. Condition of exposed root surface
  4. Traumatic occlusal forces
    1. Primary occlusal trauma
    2. Secondary occlusal trauma
    3. Orthodontic forces
  5. Prostheses and tooth-related factors that modify or predispose to plaque-induced gingival diseases/periodontitis
    1. Localized tooth-related factors
    2. Localized dental prostheses-related factors

Peri-implant diseases and conditions

[edit]

The 2018 Disease Classification of Periodontal Disease and Conditions divides this category into four subcategories:[7][page needed]

  • Peri-implant health
  • Peri-implant mucositis
  • Peri-implantitis
  • Peri-implant soft and hard tissue deficiencies

Prevention

[edit]

The most effective prevention method is what can be achieved by the patient at home, for example, using the correct tooth brushing technique, interdental cleaning aids such as interdental brushes or floss and using a fluoridated toothpaste. It is also advised that patients receive bi-annual check ups from their dental health provider along with thorough cleaning.[17]

Treatment

[edit]

Along with specialist periodontist treatment, a general dentist or dental hygienist can perform routine scale and cleans using either hand instruments or an ultrasonic scaler (or a combination of both). The practitioner can also prescribe specialized plaque-removal techniques (tooth brushing, interdental cleaning). The practitioner can also perform a plaque index to indicate to the patient areas of plaque they are not removing on their own. This can be removed through the procedure of a dental prophylaxis.[17]

Aetiology

[edit]

The primary aetiological factor for periodontal disease is plaque biofilm of dental biofilm. A dental biofilm is a community of microorganisms attached to a hard, non-shedding surface. In the oral cavity, hard non-shedding surfaces include teeth, dental restorative materials and fixed or removable dental appliance such dentures.[16] It is this adherence to non-shedding surfaces that allows bacteria in a dental biofilm to have unique characteristics of clinical significance. The stages of biofilm formation:

  1. Formation of an acquired pellicle: involves selective absorption of salivary and GCF molecules through an electrostatic affinity with hydroxyapatite.[20]
  2. Bacterial transportation: bacteria will readily adhere to the acquired pellicle through adhesins, proteins and enzymes within one to two hours.[20]
  3. Reversible interaction: there is electrostatic attraction or hydrophobic interaction between microorganisms and the tooth surface.[20]
  4. Irreversible interaction: bacterial adhesins recognise specific host receptors such as pili and outer membrane proteins. The different species of bacteria bind together and require specific receptors to interact with the pellicle.[21]
  5. Co-adhesion: there is a natural affinity for oral microorganisms to adhere to one another which is termed co‐adhesion. Co-adhesion involves the adherence of planktonic or single culture cells to already attached organisms on a surface. The organisms which make first contact with the surface and allow the platform for later co-adhesion of bacteria are called early colonisers; they facilitate the formation of complex multispecies dental biofilms.[20]
  6. Multiplication: through continued growth and maturation of existing plaque micro-organisms and the further recruitment of later colonisers.[20]
  7. Climax community (homeostasis): after a prolonged period of stability, the bacterial community has sufficient nutrients and protection to survive. These complex biofilms are usually found in hard to cleanse areas. Nutrition is provided from dietary consumption of the host for supra-gingival biofilm organisms and from blood and GCF for the sub gingival biofilm organisms.[20]
  8. Detachment: from one surface to another or within biofilm allows colonization at remote sites.[22]

Bacteria contained within the biofilm are protected by a slimy extracellular polysaccharide matrix which helps to protect them from the outside environment and chemotherapeutics agents. An example of a chemotherapeutic agent is an antiseptic such as chlorhexidine mouth-rinse or antibiotics. Thus, antibiotics are not generally used in the treatment of periodontal disease, unlike other bacterial infections around the body. The most effective way to control the plaque biofilm is via mechanical removal such as toothbrushing, interdental cleaning or periodontal debridement performed by a dental professional.[22]

Pathogenesis

[edit]

An individual's host response plays an important role in the pathogenesis of periodontal disease. Even in a mouth where the gingiva appear healthy, there is constant low-level inflammatory response facilitated by the host to manage the constant bacterial load of plaque micro-organisms. Leukocytes and neutrophils are the main cells that phagocytose bacteria found in the gingival crevice or pocket. They migrate from the tissues in a specialized exudate called gingival crevicular fluid also known as GCF. Neutrophils are recruited to the gingival crevice area as they are signalled to by molecules released by plaque microorganisms. Damage to epithelial cells releases cytokines which attract leukocytes to assist with the inflammatory response. The balance between normal cell responses and the beginning of gingival disease is when there is too much plaque bacteria for the neutrophils to phagocytose and they degranulate, releasing toxic enzymes that cause tissue damage. This appears in the mouth as red, swollen and inflamed gingiva which may bleed when probed clinically or during tooth brushing. These changes are due to increased capillary permeability and an influx of inflammatory cells into the gingival tissues. When gingival disease remains established and the aetiology is not removed, there is further recruitment of cells such as macrophages, which assist with the phagocytic digestion of bacteria, and lymphocytes, which begin to initiate an immune response.[23] Pro-inflammatory cytokines are produced inside the gingival tissues and further escalate inflammation, which impacts the progression of chronic systemic inflammation and disease. The result is collagen breakdown, infiltrate accumulation as well as collagen breakdown in the periodontal ligament and alveolar bone resorption. At this stage, the disease has progressed from gingivitis to periodontitis and the loss of supporting periodontium structure is irreversible.[22]

Risk factors

[edit]

A risk factor is a variable that in health can be defined as "a characteristic associated with an increased rate of a subsequently occurring disease".[24] Risk factors are variables that contribute to disease, rather than being factors that induce disease. Risk factors may be seen as modifiable and non-modifiable. Modifiable risk factors are often behavioural in nature and can be changed by the individual or environmental circumstances, whereas non-modifiable factors are usually intrinsic to an individual's genetics and cannot be changed. To determine risk factors for a disease, evidence-based research and studies are needed for evidence, with longitudinal studies giving the most statistically significant outcomes and the best reliability for determining risk factors. Risk factors often coexist with other variables, rarely acting alone to contribute to a disease. Risk factors can be genetic, environmental, behavioural, psychological, and demographic in nature.[citation needed]

There are many risk factors that contribute to placing an individual at higher risk for developing gingival and periodontal diseases. However, the only aetiological factor for periodontal disease is bacterial plaque, or biofilm. Identification of one's risk factors plays an important role in the diagnosis, treatment and management of periodontal diseases. It was previously believed that each human being had the same risk of developing periodontal diseases, but through the identification and classification of risk factors, it has become well understood that each individual will have a differing array of risk factors that generate susceptibility and contribute to severity of periodontal disease.

Individual, modifiable risk factors include:

  • Tobacco smoking: tobacco smoking is firmly established as a major risk factor for periodontal disease, with the relationship between smoking exposure and periodontal tissue destruction being supported strongly by various research papers.[25] Smoking decreases the healing abilities of the oral tissues by destroying blood vessels and supply and preventing essential immune-defence organisms from penetrating the tissues. Therefore, pathogenic bacteria are able to destruct the periodontal tissues more rapidly and escalate the severity of disease.[26] Although the clinical signs of inflammation are less pronounced, smokers have a larger portion of sites with deep pocketing depths and loss of clinical attachment when compared with nonsmokers.[27] Smoking cessation and counselling is an integral part of a dental professional's work with periodontal disease patients. Smoking cessation has been proven to prevent progression of periodontal disease and to return the oral microflora to a less pathogenic microbial state.[28]
  • Alcohol consumption: more research needs to be conducted in the form of longitudinal studies on the effects of alcohol on the periodontal tissues. However, current studies suggest that alcohol consumption moderately increases one's risk for progression of periodontal disease.[29]
  • Diabetes mellitus: diabetes falls under the category of modifiable risk factors as although it cannot be cured, it can be controlled, which greatly helps periodontal disease control. A clear two-way relationship has been established with blood glucose control directly affecting periodontal disease severity and progression, and vice versa. Periodontal disease patients with diabetes mellitus also have poorer healing abilities than those without diabetes, and hence are at an increased risk for more severe diseases if blood glucose control is poor and when healing abilities are affected by systemic disease.[24]
  • Obesity and vitamin D deficiency are both risk factors for periodontal disease that go hand in hand. Obesity is generally associated with a decreased consumption of fruits and vegetables, with an increase in foods high in fat, salt and sugar. Having a poor diet not only contributes to obesity but also results in a lack of essential nutrients, including vitamin C, D, and calcium, which all play important roles in ensuring a healthy immune system and healthy oral tissues and bone.[30]
  • Poor oral hygiene: as plaque is the only aetiological factor for periodontal disease,[31][page needed] poor oral hygiene is the most prominent risk factor in initiating, progressing and determining severity of disease. Performing brushing and interdental cleaning is perhaps one of the most effective ways at removing dental plaque biofilm and prevention of periodontal diseases.
  • Cardiovascular disease: not only does poor oral hygiene have a clear relationship with an increased risk of developing cardiovascular disease, high concentrations of cholesterol and the mechanisms of oral bacteria in the process of atherosclerosis may increase in individuals with chronic periodontitis.[32]
  • Stress: various studies have demonstrated that individuals under psychological, ongoing chronic stress are more likely to have clinical attachment loss and decreased levels of alveolar bone due to periodontal destruction.[33] This is due to the increased production of certain immune cells and interleukins, which decrease the defensive mechanisms against pathogenic bacteria, therefore increasing chances of developing periodontal disease.
  • Pregnancy: studies have shown that the oral tissues are affected and altered during pregnancy due to a decreased immune response and increased vascular blood supply and volume systemically. it is important to note that pregnancy does not cause gingival and periodontal diseases but may exacerbate the inflammatory response to a pre-existing disease. It is also important to note that pregnancy does not detract minerals from the oral tissues or teeth as previously thought and heard in old wives' tales. Existing disease often presents during pregnancy due to an altered oral environment, and not merely due to pregnancy causing disease. These effects can be prevented by good oral hygiene through toothbrushing and interdental cleaning.[34]

Non-modifiable risk factors include:

  • Genetics and the host response have been shown to play an important role in periodontal disease development in studies on identical twins and isolated indigenous populations.[35] Periodontal disease also may result due to an abnormal or decreased immune response, rather than aggressive properties of bacterial pathogens.[36]
  • Osteoporosis: in individuals with osteoporosis, studies have shown that alveolar bone is less dense than in a healthy adult. However, this does not demonstrate a relationship with periodontal pathogens or clinical attachment loss, therefore more research is needed to investigate if osteoporosis is a true risk factor for periodontal disease.[24]
  • Drug-induced disorders: many drugs and medications can have an adverse effect on the periodontal tissues, through contributing to various oral conditions such as dry mouth and gingival enlargement (gingival hyperplasia).[37] It is crucial that dental professionals ensure that poly-pharmacy patients have medical history reviewed at each visit to correctly evaluate the patient's risk and determine appropriate course of action for dental treatment.
  • Haematological disorders: important cells and nutrients carried in the blood to the periodontal tissues are crucial for the tissues' defence mechanisms and response to toxins and pathogens, gas exchange and efficient hemostasis. Therefore, red blood cells have a pivotal role in maintaining the health of the periodontium, meaning haematological disorders can have profound detriment to the periodontal tissues and the onset of disease.[38]

Risk characteristics must be considered in conjunction with risk factors as variables that may also contribute to increasing or decreasing one's chances of developing periodontal disease. Numerous studies show that age, gender, race, socioeconomic status, education and genetics also have strong relationships on influencing periodontal disease.

Periodontal disease is multifactorial, requiring dental and oral health professionals to have a clear and thorough understanding of the risk factors and their mechanisms in order to implement effective disease management in clinical practice.[citation needed]

Diagnosis

[edit]

Periodontitis and associated conditions are recognised as a wide range of inflammatory diseases that have unique symptoms and varying consequences. In order to identify disease, classification systems have been used to categorize periodontal and gingival diseases based on their severity, aetiology and treatments.[11] Having a system of classification is necessary to enable dental professionals to give a label to a patient's condition and make a periodontal diagnosis. A diagnosis is reached by firstly undertaking thorough examination of the patient's medical, dental and social histories, to note any predisposing risk factors (see above) or underlying systemic conditions. Then, this is combined with findings from a thorough intra and extra oral examination. Indices such as the periodontal screening record (PSR) and the Community Periodontal Index of Treatment Needs (CPITN) are also used in making a diagnosis and to order or classify the severity of disease.[39]

If disease is identified through this process, then a full periodontal analysis is performed, often by dental hygienists, oral health therapists, or specialist periodontists. This involves full mouth periodontal probing and taking measurements of pocket depths, clinical attachment loss and recession. Along with this other relevant parameters such as plaque, bleeding, furcation involvement and mobility are measured to gain an overall understanding of the level of disease. Radiographs may also be performed to assess alveolar bone levels and levels of destruction.[40]

Treatment

[edit]

Phases of periodontal therapy

[edit]

Contemporary periodontal treatment is designed based on the trimeric model, and is performed in four phases. These phases are structured to ensure that periodontal therapy is conducted in a logical sequence, consequently improving the prognosis of the patient, in comparison to indecisive treatment plan without a clear goal.

Phase I therapy (initial therapy – disease control phase)

[edit]
Non-surgical phase
[edit]

The non-surgical phase is the initial phase in the sequence of procedures required for periodontal treatment.[41] This phase aims to reduce and eliminate any gingival inflammation by removing dental plaque and calculus, restoration from tooth decay and correction of defective restoration, as these all contribute to gingival inflammation, also known as gingivitis.[41] Phase I consists of treatment of emergencies, antimicrobial therapy, diet control, patient education and motivation, correction of iatrogenic factors, deep caries, hopeless teeth, preliminary scaling, temporary splinting, occlusal adjustment, minor orthodontic tooth movement and debridement.[41]

Re-evaluation phase
[edit]

During this phase, patients are seen 3–6 weeks after initial therapy; it is required to re-evaluate the steps carried out after the phase I therapy.[41] Usually 3–6 week re-evaluation is crucial in severe cases of periodontal disease. The elements which are required to be re-evaluated are the results of initial therapy (phase I therapy), oral hygiene and status, bleeding and plaque scores and a review of diagnosis and prognosis and modification of the whole treatment plan if necessary.[42]

Phase II therapy (surgical phase)

[edit]

After post-phase I, it is necessary to evaluate the requirement of periodontium for surgery.[42] Factors identifying if the surgical phase is required are: periodontal pocket management in specific situations, irregular bony contours or deep craters, areas of suspected incomplete removal of local deposits, degree II and III furcation involvements, distal areas of last molars with expected mucogingival junction problems, persistent inflammation, root coverage and removal of gingival enlargement.

Phase III therapy (restorative phase)

[edit]

During this phase, any defects need to be restored with removable or fixed through dental prosthesis, prosthodontics, or other restoration processes.[41]

Phase IV therapy (maintenance phase)

[edit]

The last phase of periodontal therapy requires the preservation of periodontal health. In this phase, patients are required to re-visit through a scheduled plan for maintenance care to prevent any re-occurrence of the disease.[42] The maintenance phase constitutes the long-term success for periodontal treatment, thus contributing to a long relationship between the oral health therapist, dentist, or periodontist and the patient.[42]

Periodontal and restorative interface

[edit]

The prognosis of the restorative treatment is determined by the periodontal health. The goals for establishing periodontal health prior to restorative treatment are as follows:

  1. Periodontal treatment should be managed to assure the establishment of firm gingival margin prior to tooth preparation for restoration. Absence of bleeding tissue during restorative manipulation provides accessibility and aesthetic outcome.[42]
  2. Certain periodontal treatment is formulated to increase sufficient tooth length for retention. Failure to accomplish these methods prior restorations can lead to the complexity or risk of failure of treatment such as impression making, tooth preparation and restoration.
  3. Periodontal therapy should follow restorative method as the resolution of gingival inflammation may result in the repositioning of teeth or in soft tissue and mucosal changes.[42]

Standard of periodontal treatment

[edit]

Non-surgical therapy is the golden standard of periodontal therapy which consists of debridement with a combination of oral-hygiene instructions and patient motivation. It mainly focuses on the elimination and reduction of putative pathogens and shifting the microbial flora to a favourable environment to stabilize periodontal disease.[43] Debridement is thorough mechanical removal of calculus and dental biofilm from the root surfaces of the tooth.[44] Debridement is the basis of treatment for inflammatory periodontal diseases and remains the golden standard for surgical and non-surgical treatment in the initial therapy. It is conducted by hand instrumentation such as curettes or scalers and ultrasonic instrumentation.[45] It requires a few appointments, depending on time and clinician skills, for effective removal of supragingival and subgingival calculus, when periodontal pockets are involved. It can assist in periodontal healing and reduce periodontal pocketing by changing the subgingival ecological environment.[45] Prevention of periodontal disease and maintenance of the periodontal tissues following initial treatment requires the patient's ability to perform and maintain effective dental plaque removal.[45] This requires the patient to be motivated in improving their oral hygiene and requires behaviour change in terms of tooth brushing, interdental cleaning, and other oral hygiene techniques.[46] Personal oral hygiene is often considered an essential aspect of controlling chronic periodontitis. Research has shown that it is important to appreciate the motivation of the patient behaviour changes that have originated from the patient.[46] Patients must want to improve their oral hygiene and feel confident that they have the skills to do so. It is crucial for the clinician to encourage patient changes and to educate the patient appropriately. Motivational interviewing is a good technique to ask open-ended questions and express empathy towards the patient.

Role of the oral health therapist

[edit]

An oral health therapist is a member of the dental team who is dual-qualified as a dental hygienist and dental therapist. They work closely with dentists and a number of dental specialists including periodontists. It is common for the oral health therapist to be involved in the treatment of gingival and periodontal diseases for patients. Their scope of practice in this area includes oral health assessment, diagnosis, treatment and maintenance and referral where necessary. They also have expertise in providing oral health education and promotion to support the patient to maintain their at-home oral care.[47] Oral health therapists are employed by the dental team to share the responsibilities of care. They are an important asset as they have been uniquely and specifically trained in preventative dentistry and risk minimization. This allows the dental team to work more competently and effectively as dentists can manage more complex treatments or significantly medically compromised patients.[48]

Periodontist

[edit]

A periodontist is a specialist dentist who treats patients for periodontal-related diseases and conditions. They are involved in the prevention, diagnosis and treatment of periodontal disease. Periodontists receive further specialist training in periodontics after completing a dental degree. Periodontists provide treatments for patients with severe gingival diseases or complex medical histories. Periodontists offer a wide range of treatments including root scaling and planing, periodontal surgery, implant surgery and other complex periodontal procedures.[49]

Dental implant

List of procedures performed by a periodontist:[49]

  • non-surgical treatments
  • gum graft surgery
  • laser treatment
  • regenerative procedures
  • dental crown lengthening
  • dental implants
  • pocket reduction procedures
  • plastic surgery procedures

Training

[edit]

Before applying to any postgraduate training program in periodontology, one must first complete a dental degree.

Canada

[edit]

Canadian programs are accredited by the Commission on Dental Accreditation of Canada[50] and are a minimum of three years in length and usually culminate with a master (MSc or MDent) degree. Graduates are then eligible to sit for the fellowship exams with the Royal College of Dentists of Canada. Dentistry is a regulated profession. To become a licensed dentist in Canada one must have a BDS, DDS, or DMD degree and be certified by the National Dental Examining Board of Canada.[51]

United States

[edit]
UCLA School of Dentistry periodontics graduate clinic

The American Dental Association (ADA)-accredited programs are a minimum of three years in length. According to the American Academy of Periodontology, U.S.-trained periodontists are specialists in the prevention, diagnosis and treatment of periodontal diseases and oral inflammation, and in the placement and maintenance of dental implants.[52] Many periodontists also diagnose and treat oral pathology. Historically, periodontics served as the basis for the speciality of oral medicine. Following successful completion of post-graduate training a periodontist becomes board-eligible for the American Board of Periodontology examination.[citation needed]

Maintenance

[edit]

After periodontal treatment, whether it be surgical or non-surgical, maintenance periodontal therapy is essential for a long-term result and stabilization of periodontal disease. There is also a difference in the maintenance of different types of periodontal disease, as there are different types, such as:[53]

Gingivitis

[edit]

The reversible inflammation of the gums is easily prevented by patients. After the removal of the inflammatory product, usually plaque or calculus, this allows the gums room to heal. This is done by patients thoroughly cleaning teeth every day with a soft bristle toothbrush and an interdental aid. This can be floss, interdental brushes, or whatever is preferred by the patient. Without patient compliance and constant removal of plaque and calculus, gingivitis cannot be treated completely and can progress to irreversible periodontitis.[54]

Necrotizing ulcerative gingivitis (NUG)

[edit]

Also acute necrotizing ulcerative gingivitis and necrotizing ulcerative periodontitis, it is a type of periodontal disease different than many other periodontal diseases. Clinical characteristics include gingival necrosis (breakdown of the gums), gingival pain, bleeding, halitosis (bad breath), as well as a grey colour to the gingiva and a punched out appearance.[clarification needed] It is treated through debridement, usually under local anaesthetic due to immense pain. To maintain and treat the condition completely, a chlorhexidine mouthwash should be recommended to the patient to use twice daily, oral health instruction should be provided (using a soft bristle toothbrush or electric toothbrush twice a day) and an interdental cleaning aid, such as floss or interdental brushes, which cleans the areas that the toothbrush cannot reach. The patient should also be educated on proper nutrition and diet and healthy fluid intake. Smoking cessation should occur not only to completely eradicate the disease but also for the health of the patient. Pain control can be done through ibuprofen or paracetamol/acetaminophen. In the case of an immunocompromised patient, antibiotics should be prescribed. Assessment of treatment should be done after 24 hours of treatment and continued every 3–6 months until signs and symptoms are resolved and gingival health and function restored.[55]

Chronic periodontitis

[edit]

The inflammation of the gums and irreversible destruction of the alveolar bone and surrounding structures of the teeth, which is usually slow progressing but can have bursts. Local factors explain presence of disease, such as diet, lack of oral hygiene, plaque accumulation, smoking, etc. It is characterized by pocket formation and recession of the gingiva (shrinkage of the gums). Treatment and maintenance are important in stopping disease progression and to resolve the inflammation. Treatment usually consists of scaling and root planning, surgical therapy, and regenerative surgical therapy. After treatment, patient care and regular maintenance check-ups are important to completely eradicate the disease and present its recurrence. This is done through plaque control and removal: twice daily toothbrushing and daily interdental cleaning; chlorhexidine mouthwash can also be effective. The patient should also present to a dentist for maintenance check-ups at least every three months for an in-office check-up and if necessary, plaque control.[56]

See also

[edit]

Explanatory notes

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia
from Grokipedia
Periodontology, also known as periodontics, is the branch of dentistry dedicated to the study, prevention, diagnosis, and treatment of diseases affecting the periodontium—the specialized tissues supporting the teeth, including the gingiva (gums), periodontal ligament, cementum, and alveolar bone. This field addresses chronic inflammatory conditions such as gingivitis and periodontitis, which arise from bacterial plaque accumulation and can lead to tissue destruction, bone loss, and tooth mobility if untreated. Periodontists, the specialists in this area, also manage the surgical placement and maintenance of dental implants to restore function and aesthetics in cases of tooth loss. Periodontal diseases represent a significant concern, with approximately 40% of U.S. adults aged 30 and older affected by some form of periodontitis based on data from , and increasing to 60% among those 65 and older. These conditions are primarily preventable through practices like brushing, flossing, and professional cleanings, but advanced cases often require specialized interventions such as , gum grafts, or regenerative procedures to halt disease progression. Periodontists complete an additional three years of postgraduate training beyond , equipping them to handle complex cases that general dentists may refer. Beyond oral health, periodontology intersects with systemic medicine, as untreated has been associated with increased risks of cardiovascular events, complications, and adverse outcomes, underscoring the importance of interdisciplinary care. The field continues to evolve with evidence-based guidelines, such as those from the American Academy of Periodontology, emphasizing staging and grading of periodontitis for personalized treatment planning.

Periodontium

Gingiva

The gingiva, also known as the gums, is the soft mucosal tissue that surrounds the necks of the teeth and forms a protective collar around them within the oral cavity. It is a key component of the periodontium, extending from the free gingival margin to the mucogingival junction, where it meets the alveolar mucosa. The gingiva is divided into three main parts: the free gingiva, which borders the teeth and forms the gingival sulcus; the attached gingiva, which is firmly bound to the underlying periosteum and tooth; and the interdental gingiva, which occupies the spaces between adjacent teeth. Histologically, the gingiva consists of an outer epithelial layer and an underlying stroma. The is primarily stratified squamous keratinized on the outer surface, providing a tough barrier, while the inner aspects include the non-keratinized sulcular epithelium lining the and the junctional epithelium, a specialized short layer (typically 1-2 cells thick apically) that attaches directly to the surface via hemidesmosomes. The , or , comprises dense fibers (predominantly type I, making up about 60% of the tissue), fibroblasts, and including proteoglycans and glycoproteins, with blood supply primarily from supraperiosteal vessels branching from the superior alveolar arteries. The primary functions of the gingiva include serving as a physical barrier to protect the underlying periodontal ligament and alveolar bone from mechanical trauma and microbial invasion from the oral environment. It facilitates tooth attachment through the (a shallow crevice of 0.5-1.5 mm depth) and the epithelial attachment at the base of the sulcus, contributing to overall periodontal stability in conjunction with the periodontal ligament. Additionally, the gingiva supports immune surveillance and minor roles in sensation and nutrient absorption. In terms of specific anatomy, the free gingival margin is located approximately 1-3 mm coronal to the cemento-enamel junction (CEJ), forming a scalloped edge that adapts to the contour. The attached gingiva is immobile, exhibits a stippled or orange-peel-like surface due to epithelial pegs extending into the , and varies in width from 1 to 9 mm depending on the and factors. The interdental papilla, a triangular projection of the interdental gingiva, fills the embrasures between teeth to prevent food impaction and maintain hygiene. Clinically, the gingiva's health is assessed via probing depth, which measures the distance from the free gingival margin to the base of the sulcus or ; normal depths range from 1-3 mm, indicating intact attachment.

Alveolar Mucosa

The alveolar mucosa is a type of lining mucosa that forms the mobile soft tissue covering the alveolar processes of the and , extending from the mucogingival junction to the vestibule of the oral cavity. It appears as a thin, , and shiny membrane due to its rich vascular supply and lack of keratinization, distinguishing it from the more robust attached gingiva. Histologically, the alveolar mucosa consists of a non-keratinized overlying a rich in elastic and collagenous fibers, with few and dermal papillae. This layer often lacks a distinct in areas directly adjacent to , allowing for greater mobility, and its abundant vessels contribute to its reddish hue. In contrast to the para-keratinized epithelium of the attached gingiva, the alveolar mucosa's non-keratinized surface provides flexibility but reduced resistance to abrasion. The primary functions of the alveolar mucosa include facilitating movements of the , cheeks, and during speech, , and mastication by its elastic properties. It also serves as a protective barrier, separating the oral cavity from underlying muscles and while permitting sensory through its vascular and neural components. Clinically, the alveolar mucosa exhibits a smooth texture and high mobility, which can lead to exposure of underlying structures in cases of trauma, though its supports rapid healing. Its color may vary with pigmentation, reflecting individual skin tones, and it is identifiable by its demarcation at the mucogingival line, where it transitions to the firmly attached gingiva.

Periodontal Ligament

The periodontal ligament (PDL) is a specialized fibrous that suspends the teeth within the alveolar sockets, connecting the covering the root to the alveolar . It forms a thin layer approximately 0.15 to 0.38 mm in width, which varies slightly depending on type and location, with the thinnest portions near the alveolar crest. This structure provides essential support while allowing for controlled under functional loads. The composition of the PDL includes principal fibers, ground substance, and a diverse array of cells. The principal fibers, primarily composed of with a significant proportion of type III collagen forming cofibrils, are organized into distinct bundles that anchor the . These bundles consist of alveolar crest fibers extending between the alveolar crest and , horizontal fibers running perpendicular to the surface in the coronal third, oblique fibers slanting from to in the middle third (comprising the majority of the ligament), apical fibers encircling the apex, and interradicular fibers stabilizing multi-rooted teeth between roots. The ground substance, which accounts for a substantial portion of the , is rich in water (about 70%) and glycosaminoglycans such as , along with glycoproteins like , contributing to the tissue's hydration and resilience. Cellular components include fibroblasts (the predominant , responsible for synthesis and remodeling), cementoblasts (involved in formation), and osteoblasts (supporting alveolar maintenance), alongside other elements like epithelial rests of Malassez and progenitor cells. The PDL serves multiple critical functions in oral health. It acts as a during mastication, distributing occlusal forces through its viscoelastic properties to protect underlying tissues from excessive stress. Sensory reception is facilitated by mechanoreceptors embedded within the , which detect position and movement with high sensitivity (to forces as low as a few grams and displacements of 10–100 μm), relaying proprioceptive information to the . Additionally, the PDL plays a nutritive role by housing a rich vascular network that supplies oxygen and nutrients to the adjacent and alveolar bone while facilitating waste removal. Developmentally, the PDL originates from the , a mesenchymal structure derived from cranial cells surrounding the developing germ, with fibroblasts differentiating to form initial fiber bundles as the root elongates and the tooth erupts. The ligament's width and cellular activity decrease with age, reflecting reduced proliferative capacity of stem cells and overall tissue remodeling. In clinical contexts, the PDL widens in response to orthodontic forces, enabling controlled tooth movement through adaptive and deposition on opposing sides. It is also a primary site of inflammation during periodontitis, where inflammatory mediators disrupt fiber integrity and cellular function.

Alveolar Bone

The alveolar bone constitutes the bony component of the , serving as a specialized osseous structure that supports the by forming tooth sockets known as alveoli. It is derived from mesenchymal stem cells of the and comprises two main types: the alveolar bone proper, also termed bundle bone, which is a thin layer of compact directly surrounding the tooth and penetrated by Sharpey's fibers from the periodontal ligament; and the supporting bone, which includes the basal bone forming the jaw's foundational structure and the surrounding trabecular . Structurally, the alveolar bone features outer compact cortical plates, particularly thin on the buccal and lingual surfaces, enclosing an inner network of spongy trabecular bone that provides lightweight support and houses marrow spaces. The alveolar bone proper manifests as a , characterized by numerous perforations () that transmit blood vessels and nerves to the periodontal ligament, and it appears as the radiopaque on dental radiographs. Interdental septa, formed between adjacent alveoli, are typically thicker and more robust, contributing to the overall architecture that resists occlusal stresses. Histologically, alveolar bone resembles long bone but is adapted for dental support, containing osteocytes within lacunae of the calcified matrix, osteoblasts lining formative surfaces to deposit new bone, and osteoclasts facilitating resorption on Howship's lacunae. The compact cortical regions are organized into concentric lamellae surrounding central Haversian canals that house neurovascular bundles, while the trabecular regions consist of interconnecting spicules of bone trabeculae oriented along lines of stress. This cellular and matrix organization enables dynamic adaptation to functional demands. The primary functions of alveolar bone include providing anchorage for teeth via the bony walls of the alveoli, where it interfaces with the periodontal ligament to secure principal fiber attachments, and undergoing continuous remodeling to distribute masticatory forces and maintain periodontal stability. This remodeling process balances bone formation and resorption, influenced by biomechanical loading, to preserve tooth position and integrity. Alveolar bone develops postnatally following , with osteogenesis initiated by dental follicle-derived cells that form the around the erupting . In the absence of a tooth, such as after extraction, the bone resorbs rapidly due to lack of functional stimuli, often leading to dimensional changes in the ridge. Over time, it thins with advancing age due to reduced remodeling activity and can further diminish in response to inflammatory conditions like periodontitis, altering the overall support architecture. Specific features, such as the fenestrated nature of thin buccal and lingual plates and the supportive role of interdental , underscore its vulnerability to localized resorption while highlighting adaptations for efficient load-bearing.

Cementum

Cementum is a specialized, avascular, mineralized that covers the anatomical of the , serving as the interface for attachment to the periodontal and alveolar . It exists in two primary types: acellular cementum, which is located in the coronal third of the and lacks embedded cells, appearing as a thin layer approximately 20-50 μm thick; and cellular cementum, found primarily in the apical two-thirds, which is thicker and contains cementocytes embedded within lacunae. The acellular form predominates near the cemento-enamel junction (CEJ), while the cellular type incorporates both intrinsic and extrinsic fiber components, contributing to its adaptive properties. The composition of cementum consists of approximately 45-50% inorganic material, primarily crystals, which provide rigidity; about 30% organic matrix, dominated by (over 90%) along with non-collagenous proteins such as bone sialoprotein, , and proteoglycans; and roughly 23% water, which supports cellular activity in the cellular variant. These components enable cementum to mineralize similarly to but with slower apposition rates, resulting in a tissue that is less vascular and more stable under mechanical stress. Cementum forms through the activity of cementoblasts, mesenchymal cells derived from the dental follicle that differentiate under the influence of Hertwig's epithelial root sheath (HERS). During root development, HERS fragments to allow cementoblast migration onto the dentin surface, where they secrete an organic matrix that mineralizes incrementally, marked by lines of Salter that reflect periodic deposition phases. This process begins apically and proceeds coronally, with acellular cementum forming first followed by cellular layers in more mature stages. Key functions of include anchoring the principal fibers of the periodontal ligament (PDL) via Sharpey's fibers, which insert perpendicularly into its matrix to stabilize the during occlusal forces. Additionally, it facilitates repair of root resorption defects by enabling secondary cementum deposition, thereby maintaining periodontal integrity and compensating for functional wear over time. Thickness of varies along the root, starting thin (around 20-50 μm) at the coronal portion and increasing apically to 150-600 μm or more, depending on type and age, with no coverage on the enamel surface except at the CEJ where it may butt or slightly overlap. This gradient supports greater load distribution at the root apex. Clinically, can exhibit , an abnormal thickening often associated with conditions like Paget's disease or prolonged orthodontic forces, which may alter root morphology without necessarily impairing function. It also serves as a potential site for , where direct fusion occurs between and alveolar , leading to immobility and possible resorption in pathological states.

Epidemiology

Prevalence and Distribution

Periodontal diseases, encompassing and periodontitis, exhibit high global prevalence, with affecting up to 90% of due to its association with plaque accumulation. Periodontitis, a more advanced form, impacts approximately 61% of aged 30 years and older worldwide, while severe periodontitis affects about 19% of the global , equating to over 1 billion cases. In 2021, the estimated 951 million cases of among working-age (aged 15-69 years), with an age-standardized prevalence rate of 13,200 per 100,000 . Prevalence increases markedly with age, reflecting cumulative exposure to risk factors. Among adults under 30 years, mild predominates, affecting a majority during due to hormonal changes and poor . For periodontitis, rates are higher in older age groups globally, with severe forms more common in older populations. In the United States, data from the and Nutrition Examination Survey (NHANES) 2009-2014 indicate that periodontitis prevalence escalates from approximately 30% in adults aged 30-39 years to 68% in those aged 65 and older. Geographic variations highlight disparities, with higher prevalence in low- and middle-income countries, particularly in regions like and , compared to high-income regions such as , driven by limited access to oral care. Low sociodemographic index (SDI) regions bear the greatest burden, with age-standardized prevalence rates for periodontitis significantly higher than those in high-SDI areas. Demographic factors further influence distribution: males experience higher rates than females (e.g., 50% vs. 33% in U.S. adults aged 30+), current smokers have nearly double the risk compared to nonsmokers (62% vs. approximately 35%), and certain ethnic groups, such as non-Hispanic Blacks (59%) and Hispanics (64%), show elevated prevalence relative to (41%) in the United States. In the U.S., NHANES data from 2009-2014 confirm that 42% of dentate adults aged 30 years and older have periodontitis, with 7.8% experiencing severe forms. Periodontal diseases impose a substantial burden, with severe periodontitis alone accounting for approximately 6.9 million disability-adjusted life years (DALYs) in 2021, according to estimates from the 2021. This metric reflects the combined impact of years of life lost due to premature mortality and years lived with , highlighting the condition's role in chronic morbidity worldwide. Economically, oral conditions including periodontitis contribute to an annual global cost exceeding $710 billion, encompassing $387 billion in direct treatment expenditures and $323 billion in lost productivity, with periodontal diseases specifically linked to $82 billion in . These figures underscore the socioeconomic strain, particularly in low- and middle-income countries where access to care is limited, exacerbating disparities in health outcomes. Trends in the burden of severe periodontitis show stability in global age-standardized prevalence and DALY rates from 1990 to , with rates remaining around 12,500 per 100,000 and 80.9 per 100,000, respectively, though absolute case numbers have risen due to and aging. In high-income countries, improved practices and widespread fluoridation have contributed to declines in severe periodontitis prevalence, with age-standardized rates decreasing in regions with high socio-demographic index scores. Conversely, in developing nations, and associated changes have driven increases in prevalence, with low-income areas reporting up to 1.8 times higher odds of severe disease compared to high-income settings. Beyond oral health, periodontal diseases and resultant are associated with broader systemic impacts, including heightened risks of and cardiovascular events. , often a sequela of advanced periodontitis, increases the likelihood of among older adults, as edentulous individuals are more prone to dietary restrictions and nutrient deficiencies. Similarly, meta-analyses indicate that elevates the risk of coronary heart disease by approximately 1.5-fold, independent of traditional cardiovascular risk factors, through mechanisms such as chronic inflammation. Projections suggest a growing burden if current trends persist, with severe periodontitis cases expected to exceed 1.5 billion globally by 2050, a 44% increase from 2021 levels, driven by aging populations and persistent inequities in care access. The further compounded this by disrupting routine dental services from 2020 to 2022, leading to delayed treatments and a rise in untreated periodontal cases, which heightened risks of disease progression and associated complications.

Classification of Periodontal and Peri-Implant Diseases and Conditions

Overview of the 2018 AAP/EFP Classification

The 2018 classification of periodontal and peri-implant diseases and conditions was developed during a joint workshop held November 9–11, 2017, in , co-sponsored by the American Academy of Periodontology (AAP) and the European Federation of Periodontology (EFP). This framework, published in 2018 across the Journal of Clinical Periodontology and Journal of Periodontology, replaced the 1999 AAP classification system and eliminated the previous distinction between "chronic" and "aggressive" forms of periodontitis, unifying them under a single category of periodontitis to better reflect disease progression and risk factors. At its core, the classification employs a multi-dimensional staging and grading system to assess disease severity, extent, complexity, and rate of progression. Staging categorizes periodontitis into four stages (I–IV) based on the severity and extent of disease, primarily using interdental clinical attachment loss (CAL) as the key metric, supplemented by radiographic bone loss (RBL), probing depths, tooth loss due to periodontitis, and complexity factors such as vertical bone loss, furcation involvement, and masticatory dysfunction; for example, Stage I features 1–2 mm CAL and <15% RBL in the coronal third, while Stage IV involves extensive CAL (≥5 mm at the most affected site), severe RBL extending to or beyond the middle third, and significant tooth loss leading to functional impairment. Grading further stratifies risk into three levels (A–C), evaluating progression rate through direct evidence (e.g., longitudinal CAL change over 5 years) or indirect indicators like the percentage of bone loss divided by age, modified by risk factors such as smoking status and glycemic control; Grade A indicates slow progression (<0.25 bone loss/age ratio, no smoking, HbA1c <7.0%), Grade B moderate (0.25–1.0 ratio, <10 cigarettes/day), and Grade C rapid (>1.0 ratio, ≥10 cigarettes/day or HbA1c ≥7.0%). This approach integrates CAL, RBL, tooth loss attributable to periodontitis, and systemic factors like diabetes to provide a comprehensive, patient-centered evaluation that accounts for both historical damage and future risk. Key changes in the 2018 system include the introduction of categories for gingival diseases induced by non-plaque causes (e.g., allergic or traumatic etiologies), recognition of periodontitis as a manifestation of systemic diseases (such as genetic disorders or immunosuppression), and the full integration of peri-implant diseases and conditions alongside periodontal ones for the first time. These updates shift from a purely descriptive model to one emphasizing etiology, risk assessment, and interdisciplinary care. The classification guides clinical diagnosis by establishing clear case definitions, informs prognosis through progression grading, and supports tailored treatment planning by incorporating complexity and risk modifiers. Validation studies up to 2025 have demonstrated its high sensitivity for early detection and moderate inter-examiner reliability (kappa 0.37–0.85), with 78% of surveyed clinicians adopting it as an improvement over prior systems, though it shows no superior predictive power for tooth loss compared to the 1999 classification. Despite its advancements, the system has limitations, including the reliance on longitudinal data for accurate grading, which is often unavailable and reduces precision in initial assessments. Implementation challenges persist, such as subjectivity in borderline staging (e.g., distinguishing Stage III from IV) and complexity in differentiating early periodontitis from , as highlighted in 2025 reviews noting lower diagnostic consistency among general dentists.

Periodontal Health, Gingivitis, and Gingival Diseases

Periodontal is characterized by the absence of clinical signs of and stable periodontal tissues. Clinically, it is defined by (BOP) at less than 10% of sites, probing depths (PD) of 3 mm or less, and no clinical attachment loss. Radiographically, there is no evidence of alveolar bone loss beyond normal age-related changes. Biologically, periodontal involves a stable, symbiotic subgingival with low levels of and no ongoing tissue destruction. Plaque-induced gingivitis represents a reversible inflammatory condition of the gingiva caused by accumulation. It is diagnosed when BOP exceeds 10% of sites, with no clinical attachment loss or radiographic bone loss, distinguishing it from more advanced disease. This form of can be localized (affecting <30% of sites) or generalized (>30% of sites) and is fully reversible upon effective plaque control. Prevalence among adults ranges from 90% to 100% in various populations, highlighting its commonality as an early response to poor . Non-plaque-induced gingival diseases arise from factors unrelated to bacterial plaque, often linked to systemic conditions, medications, or environmental influences. These include genetic or developmental disorders, inflammatory or reactive processes, and infections. Drug-influenced gingival overgrowth, such as that caused by , cyclosporine, or , results in fibrous that may require surgical intervention if persistent. Nutritional deficiencies, notably ascorbic acid () deficiency leading to , manifest as gingival bleeding, ulceration, and swelling due to impaired synthesis. Allergic reactions, such as from flavorings or spices, present with diffuse and , while infectious causes like produce pseudomembranous lesions or . Specific non-plaque-induced conditions include pregnancy-associated , which affects 60-75% of pregnant individuals due to hormonal changes exacerbating plaque response, resulting in gingival swelling and increased BOP, particularly in the second and third trimesters. Puberty-associated similarly arises from elevated levels, leading to heightened gingival in adolescents. Linear gingival , often seen in individuals with , features a distinct erythematous band along the marginal gingiva, potentially linked to candidal infections or immune dysregulation, with variable in affected populations. Diagnostic criteria for periodontal health, gingivitis, and gingival diseases are outlined in the 2018 American Academy of Periodontology (AAP) and European Federation of Periodontology (EFP) classification, which designates periodontal health as Stage 0 with no attachment loss and minimal . is classified separately from periodontitis, emphasizing its reversibility through plaque removal, assessed via clinical indices like BOP and PD measurements. Recent 2025 research integrates microbiome stability metrics, such as low dysbiosis indices and predominance of commensal species like and , to refine definitions beyond clinical parameters alone. If plaque-induced remains untreated, it may progress to periodontitis.

Periodontitis

Periodontitis is a microbially-associated, host-mediated inflammatory that results in progressive loss of the periodontal ligament and alveolar bone, leading to the formation of periodontal pockets and, ultimately, if untreated. It is characterized by clinical attachment loss (CAL) around teeth in a progressive pattern, initiated by dysbiotic subgingival biofilms that trigger an exaggerated host . The 2018 American Academy of Periodontology (AAP) and European Federation of Periodontology (EFP) classification integrates staging to assess severity and complexity, grading to evaluate progression rate and risk, and extent to describe distribution, replacing previous distinctions between chronic and aggressive forms. Staging categorizes periodontitis into four stages based on measurable disease severity, extent of tissue destruction, and management complexity. Stage I (initial) features interdental CAL of 1–2 mm, radiographic bone loss (RBL) <15% of tooth length, no tooth loss due to periodontitis, maximum probing depth ≤4 mm, and primarily horizontal bone loss. Stage II (moderate) involves interdental CAL of 3–4 mm, RBL of 15–33%, loss of ≤4 teeth, maximum probing depth ≤5 mm, and mostly horizontal bone loss. Stage III (severe) includes interdental CAL ≥5 mm, RBL extending into the middle third of the root and beyond, loss of ≥5 teeth, probing depths ≥6 mm, vertical bone loss ≥3 mm deep, and Class II or III furcation involvement, often requiring complex rehabilitation. Stage IV (advanced) mirrors Stage III CAL and RBL but adds extensive complexity, such as masticatory dysfunction, severe ridge defects, or bite collapse necessitating multidisciplinary care. Staging is determined primarily by the most severe manifestations at affected sites, with modifiers for local factors like furcations or vertical defects. Grading classifies the rate of periodontitis progression and risk of further deterioration as Grade A (slow), Grade B (moderate), or Grade C (rapid), using direct and indirect evidence. Direct evidence includes the percentage loss/age ratio (<0.25 for Grade A, 0.25–1.0 for Grade B, >1.0 for Grade C) and longitudinal loss or CAL change (no loss over 5 years for Grade A, <2 mm over 5 years for Grade B, ≥2 mm over 5 years for Grade C, ideally assessed over ≥5 years). Indirect evidence incorporates risk factors: non-smoker and no metabolic control issues for Grade A; ≤10 cigarettes/day and HbA1c <7.0% for Grade B; ≥10 cigarettes/day or HbA1c ≥7.0% for Grade C, with diabetes status influencing progression independently of glycemic control. Grading allows for modification based on response to therapy or emerging risk factors. The extent of periodontitis describes the distribution of affected sites: localized involves <30% of teeth with CAL ≥4 mm and RBL ≥15%; generalized affects >30% of such sites; and molar-incisor pattern targets primarily first molars and incisors, often seen in younger patients or specific risk profiles. This classification aids in prognostic assessment and treatment planning. Key clinical features of periodontitis include periodontal pockets >4 mm in depth, (BOP) at ≥10% of sites, radiographic evidence of horizontal or vertical alveolar bone loss, (typically in advanced stages), and furcation involvement (Class I–III, indicating interproximal root separation exposure). These signs reflect the interplay of microbial challenge and host response, with attachment loss progressing apically from the cemento-enamel junction. Models of periodontitis progression include the continuous model, positing steady, slow attachment loss over time, and the burst theory, describing episodic, rapid destructive phases interspersed with stability periods. In untreated cases, the average annual attachment loss is approximately 0.6 mm, though rates vary by individual risk factors and can accelerate in Grade C presentations. Special cases include presentations resembling localized aggressive periodontitis in young patients (typically under 30 years), characterized by rapid interproximal attachment loss and bone loss around first molars and incisors, classified as Grade C to denote high progression risk despite overall Stage II or III severity. These often require aggressive risk factor control and monitoring.

Other Conditions Affecting the Periodontium

In the 2018 classification system developed by the American Academy of Periodontology (AAP) and the European Federation of Periodontology (EFP), other conditions affecting the encompass a diverse group of non-plaque-induced pathologies that impact the gingival, periodontal ligament, , and alveolar bone, distinct from primary forms of periodontitis. These conditions are diagnosed based on their rather than staging or grading, emphasizing identification of underlying causes such as systemic disorders, acute infections, developmental anomalies, or mechanical forces, to guide targeted management. Periodontitis as a manifestation of systemic diseases represents a category where periodontal destruction arises primarily from underlying genetic or acquired disorders that impair host defenses or immune function. Representative examples include Papillon-Lefèvre syndrome, a rare autosomal recessive disorder characterized by palmoplantar hyperkeratosis and aggressive early-onset periodontitis leading to rapid alveolar bone loss and premature tooth exfoliation due to cathepsin C mutations affecting function. Similarly, leukocyte adhesion deficiency syndromes, particularly type 1 (LAD-1), result from mutations in the ITGB2 , causing defective leukocyte migration and recurrent infections, with periodontal involvement manifesting as severe gingival inflammation, attachment loss, and often requiring interdisciplinary care. These conditions highlight how systemic impairments can mimic or exacerbate plaque-induced periodontitis, but treatment prioritizes the primary disease. Necrotizing periodontal diseases, including necrotizing ulcerative gingivitis (NUG) and necrotizing ulcerative periodontitis (NUP), are acute, destructive conditions featuring rapid onset of gingival pain, ulceration, and pseudomembrane formation on interdental papillae, often accompanied by fetid odor and . NUG primarily affects the soft tissues without significant loss, while NUP extends to attachment and alveolar destruction; both are associated with predisposing factors like , , , and , such as in HIV-positive individuals. Microbial invasion by fusobacteria and spirochetes plays a role, but host susceptibility drives the , distinguishing these from . In the 2018 framework, these are classified separately due to their unique clinical presentation and non-staged progression. Periodontal abscesses are localized purulent infections within the periodontal tissues, characterized by acute , swelling, exudation, and possible systemic fever, typically arising in pre-existing periodontal pockets due to lateral involvement or reactions. Pericoronal abscesses, a subtype, occur around partially erupted teeth like third molars, where operculum entrapment of debris leads to acute and accumulation. These lesions require prompt drainage and , as untreated cases can progress to or . Endodontic-periodontal lesions involve combined pulpal and periodontal , classified by the primary source of infection: primary endodontic (originating from pulpal necrosis spreading apically to the periodontium), primary periodontal (periodontal disease extending into the pulp via accessory canals), or combined (bidirectional involvement). Communication between the system and periodontal , often via defects or fractures, facilitates this interplay, with prognosis depending on timely therapy or periodontal intervention based on the dominant . Developmental or acquired deformities and conditions affecting the include gingival overgrowth, which can be hereditary (e.g., in syndromes like hereditary gingival fibromatosis) or induced by medications such as , cyclosporine, or , leading to excessive fibrous proliferation that complicates plaque control and may require surgical excision. Enamel pearls, ectopic nodules of enamel on root surfaces, predispose to localized periodontitis by creating plaque-retentive areas and disrupting attachment apparatus integrity, often detected radiographically near furcations. Trauma from occlusion refers to injury to the from excessive occlusal forces exceeding , categorized as primary (applied to teeth with normal periodontal support, causing widening of the periodontal and mobility without attachment loss) or secondary (exacerbating pre-existing periodontitis, potentially accelerating bone loss). Orthodontically induced trauma arises from controlled forces during alignment, typically reversible with adaptation, but excessive or prolonged application can lead to root resorption or . Management involves occlusal adjustment or splinting, as evidence does not support a direct causal link to periodontitis initiation.

Peri-Implant Diseases and Conditions

Peri-implant diseases and conditions refer to inflammatory and degenerative changes affecting the tissues surrounding dental implants, analogous to periodontal diseases but occurring at the implant-mucosa and implant-bone interfaces. These conditions are classified under the 2018 American Academy of Periodontology (AAP) and European Federation of Periodontology (EFP) framework, which provides standardized case definitions to facilitate and . The classification distinguishes between , reversible limited to soft tissues, and progressive destructive lesions involving bone loss, emphasizing the role of plaque accumulation as the primary etiological factor. Peri-implant health is characterized by the absence of clinical signs of , including no , swelling, or (BOP), with probing depths typically not exceeding 3 mm and no suppuration. Radiographically, there is no evidence of bone loss beyond the initial crestal remodeling that occurs shortly after implant placement. This state reflects stable with healthy peri-implant mucosa, where direct bone-to-implant contact is maintained without intervening structures like the periodontal found around natural teeth. Peri-implant represents a reversible inflammatory condition confined to the soft tissues surrounding a functionally loaded , without concomitant loss. It is diagnosed by the presence of BOP at more than 10% of sites around the implant, often accompanied by increased probing depths due to mucosal swelling or reduced probing resistance, and suppuration may occur in some cases. Similar to , this condition is primarily driven by bacterial biofilms and can be resolved with professional mechanical and improved . Peri-implantitis is a progressive, irreversible affecting both soft and hard tissues, characterized by clinical signs of (BOP or suppuration), probing depths greater than 5 mm, and radiographic evidence of loss extending at least 1.8 mm beyond initial levels or more than 3 mm apical to the platform if no baseline radiographs are available. Unlike periodontitis, which involves loss of attachment through the periodontal , peri-implantitis leads to direct resorption of in intimate contact with the surface, potentially resulting in failure if untreated. The prevalence of peri-implantitis is approximately 20% at the patient level after 5 years of function, highlighting its clinical significance. The 2018 AAP/EFP classification also encompasses peri-implant soft and hard tissue deficiencies as distinct conditions not necessarily associated with inflammation. conditions include , where the marginal mucosa recedes apically exposing implant components; dehiscence, characterized by a loss of buccal keratinized mucosa leading to exposed threads; and peri-implant papilla deficiency, which results in interproximal space gaps affecting esthetics. These deficiencies often arise from anatomical limitations or surgical factors and differ from periodontal conditions due to the absence of a supracrestal attachment. Risk indicators for peri-implant diseases include poor , which promotes accumulation and ; , which impairs healing and increases disease susceptibility; and uncontrolled , which exacerbates inflammatory responses and loss around implants. These factors are supported by systematic reviews identifying them as consistent predictors across patient cohorts. Diagnostic criteria in the framework incorporate bleeding/suppuration indices (e.g., percentage of sites with BOP) and radiographic thresholds (e.g., marginal level changes >0.2 mm annually after the first year) to differentiate disease stages objectively.

Etiology and Pathogenesis

Microbial Etiology

Periodontal diseases are primarily initiated by the accumulation of dental plaque, a polymicrobial biofilm that adheres to tooth surfaces and gingival margins. This biofilm begins as a structured community dominated by early colonizers such as Streptococcus and Actinomyces species, which are predominantly Gram-positive aerobes and facultative anaerobes. As the biofilm matures, particularly in the subgingival environment, there is a characteristic ecological shift toward a more diverse and pathogenic consortium, favoring Gram-negative anaerobes due to the anaerobic conditions and nutrient availability in deeper periodontal pockets. This transition from a symbiotic to a dysbiotic state is central to the progression from gingivitis to periodontitis. Key pathogens within these biofilms have been identified through checkerboard DNA hybridization and other techniques, revealing distinct microbial complexes associated with disease severity. The "red complex," comprising Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola, is strongly correlated with advanced periodontitis, often co-occurring in deep pockets and exhibiting synergistic virulence. Supporting this, the "orange complex," including species like Fusobacterium nucleatum, Prevotella intermedia, and Eubacterium nodatum, acts as a bridge, facilitating the colonization and proliferation of red complex bacteria by promoting adhesion and nutrient exchange within the biofilm. These complexes underscore the polymicrobial nature of periodontal etiology, where no single species acts in isolation. Virulence factors produced by these pathogens enable biofilm persistence and tissue invasion. In P. gingivalis, gingipains—cysteine proteases—are major contributors to pathogenicity, degrading host proteins, disrupting epithelial barriers, and modulating immune responses to favor bacterial survival. Lipopolysaccharides (LPS) from Gram-negative species like P. gingivalis and T. forsythia trigger inflammatory cascades, while fimbriae facilitate initial adhesion to host cells and co-aggregation with other microbes, enhancing stability. These factors collectively promote the shift to by altering the local microenvironment. The model posits that certain keystone pathogens, particularly P. gingivalis, orchestrate the disruption of microbial , allowing low-abundance inflammophilic to thrive despite their reduced fitness in healthy states. By subverting host immunity and altering community structure, P. gingivalis enables the emergence of a pathogenic that drives chronic . Recent 16S rRNA sequencing studies have identified over 700 bacterial in the oral , with P. gingivalis consistently emerging as a keystone driver in dysbiotic shifts observed in periodontitis samples. For instance, 2023 analyses confirmed its role in promoting inflammophilic communities through and metabolic interactions. Transmission of periodontal pathogens occurs primarily through oral routes, such as close contact within families or spouses, where P. gingivalis strains can be shared via or shared utensils, establishing in susceptible individuals. While acquisition is largely endogenous to the oral cavity, these exhibit potential for systemic dissemination, invading endothelial cells and contributing to extra-oral pathologies through bacteremia or extracellular vesicles. This microbial interplay with host responses further amplifies disease progression.

Host Response and Pathogenesis

The host response in represents the body's immunological reaction to microbial in the subgingival , leading to progressive and tissue destruction if unresolved. Innate immune mechanisms initiate this process, with polymorphonuclear leukocytes (PMNs) and macrophages migrating to the site of , releasing pro-inflammatory cytokines such as interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-α) to amplify the response. These cytokines recruit additional immune cells and promote the transition to adaptive immunity, where T and B lymphocytes produce antibodies and further modulate the inflammatory environment, sustaining chronic in susceptible individuals. Tissue breakdown occurs primarily through the action of matrix metalloproteinases (MMPs), particularly MMP-8 and MMP-9, which are upregulated by bacterial products and cytokines, leading to degradation of extracellular matrix components like collagen in the periodontal ligament and connective tissue. This enzymatic activity facilitates the loss of connective tissue attachment, characterized by the apical migration of the junctional epithelium along the root surface, resulting in the formation of periodontal pockets that harbor further microbial accumulation. Concurrently, bone resorption is driven by osteoclast activation, mediated by receptor activator of nuclear factor kappa-B ligand (RANKL) expressed by inflammatory cells, which uncouples bone resorption from formation and leads to progressive alveolar bone loss. Resolution of inflammation involves counter-regulatory mechanisms, including anti-inflammatory cytokines like IL-10 that suppress pro-inflammatory signaling and promote apoptosis of excess inflammatory cells to restore homeostasis. However, in chronic periodontitis, dysregulated host responses perpetuate tissue destruction. Recent models highlight epigenetic regulation, such as DNA methylation and histone modifications, in sustaining chronic inflammation by altering gene expression in immune and stromal cells, with 2024 studies emphasizing their role in modulating cytokine production and MMP activity in diseased gingiva. These insights underscore the potential for targeted therapies addressing host susceptibility beyond microbial control.

Risk Factors

Modifiable Risk Factors

Modifiable risk factors for periodontal diseases encompass behavioral, , and environmental elements that individuals can alter to mitigate disease progression and severity. These factors influence plaque accumulation, immune responses, and tissue healing, thereby playing a pivotal role in the onset and exacerbation of conditions like gingivitis and periodontitis. Addressing them through targeted interventions can significantly improve periodontal outcomes. Poor , characterized by inadequate plaque removal, is a primary modifiable , increasing the likelihood of periodontitis by two- to five-fold compared to individuals with good practices. Effective daily brushing and flossing disrupt formation and reduce gingival inflammation, with regular professional cleanings further enhancing plaque control and preventing disease advancement. Tobacco smoking, particularly cigarette use, exerts a dose-dependent effect on periodontal health, with smokers facing approximately twice the risk of periodontitis compared to non-smokers, and heavier consumption—such as more than 10 cigarettes per day—amplifying attachment loss and bone resorption. Nicotine and other tobacco components impair vascular function and neutrophil activity, hindering wound healing and treatment efficacy in affected individuals. Diabetes mellitus represents a bidirectional modifiable , where poorly controlled (HbA1c levels exceeding 7%) elevates periodontitis susceptibility by two- to three-fold through enhanced inflammatory responses and delayed tissue repair. Glycemic management strategies, such as medication adherence and dietary control, can attenuate this risk by stabilizing immune function and reducing periodontal pocket depths. Dietary habits significantly impact the oral , with high intake of sugars and acids fostering by promoting acidogenic growth and gingival . Conversely, deficiency, often linked to low and consumption, manifests as scurvy-related , characterized by bleeding and swollen gums due to impaired synthesis. is an emerging modifiable associated with increased periodontitis risk, with meta-analyses showing approximately 1.3-fold higher odds (OR 1.31, 95% CI 1.22–1.41) in obese individuals compared to normal weight, potentially through obesity-related and impaired immune responses. can help mitigate this elevated susceptibility. Certain medications, notably calcium channel blockers like used for , induce gingival in 20% to 50% of patients, creating niches for plaque retention and complicating . Dose adjustment or alternative therapies, under medical supervision, can resolve or prevent this overgrowth. Socioeconomic factors, including limited access to dental care and , indirectly heighten periodontal risk; lower correlates with poorer hygiene practices and delayed treatment, while stress-induced elevation exacerbates and immune dysregulation. Effective interventions, such as , yield substantial benefits, with former smokers experiencing up to a 6% annual reduction in periodontitis-related risk and improved attachment levels within the first year post-quitting. These modifiable factors often interact with genetic predispositions, underscoring the value of personalized .

Non-Modifiable Risk Factors

Non-modifiable risk factors for encompass inherent biological and demographic characteristics that predispose individuals to greater susceptibility, independent of lifestyle interventions. Genetic variations play a central role, with polymorphisms in genes such as interleukin-1 (IL-1) and Fcγ receptor IIa (FcγRIIa) significantly elevating risk. For instance, the IL-1 polymorphisms, particularly in IL-1A and IL-1B, are associated with increased IL-1 production—up to 2.5 to 3.6 times higher than in non-carriers—and heightened inflammatory responses that accelerate periodontal destruction, conferring a 2- to 7-fold increased risk in susceptible populations. Similarly, the FcγRIIa H131R polymorphism influences immune complex clearance and function, showing associations with aggressive and chronic forms of periodontitis, particularly in certain ethnic groups where the H/H correlates with more severe disease progression. Familial aggregation further underscores this genetic influence, with studies estimating that 30% to 50% of periodontitis cases cluster within families due to shared hereditary factors. Age represents another key non-modifiable factor, as prevalence rises cumulatively with longevity due to prolonged microbial exposure and diminished regenerative capacity. Attachment loss and become more pronounced after age 40, with severe emerging predominantly after 60, reflecting accelerated tissue breakdown from age-related immune and reduced . This progression is evident in epidemiological data showing that while mild forms affect about 42% of U.S. adults over 30, moderate to severe cases increase sharply in older cohorts, emphasizing age as a driver of irreversible structural changes. Sex and gender differences also contribute to varying susceptibility, with males exhibiting approximately 1.5 times higher of periodontitis than females, attributed partly to biological factors like testosterone-modulated immune responses that may impair gingival healing. In females, hormonal fluctuations—such as those during —can exacerbate bone loss through links to , increasing alveolar ridge resorption and periodontal attachment compromise. Racial and ethnic disparities highlight non-modifiable influences on disease burden, with higher rates observed in populations of African and Asian descent compared to Whites. In the United States, severe periodontitis affects non-Hispanic Blacks at rates up to twice that of non-Hispanic Whites (15.6% versus 6.8%), while overall prevalence reaches 59% in Blacks and 50% in Asian Americans versus 41% in Whites, reflecting potential genetic predispositions intertwined with ancestral microbial exposures. These inequities persist even after adjusting for socioeconomic variables, underscoring inherent biological vulnerabilities. Certain systemic diseases amplify periodontal risk through immutable physiological alterations. In infection, linear gingival erythema—a hallmark of immune dysregulation—manifests as a fiery red marginal band on the gingiva and can progress to necrotizing periodontitis in immunocompromised individuals due to impaired function and opportunistic pathogens. Similarly, predisposes individuals to early-onset periodontitis, with prevalence exceeding 90% by early adulthood, driven by 21-related immune deficiencies, delayed eruption, and altered oral that facilitate rapid bone loss. Evidence from twin studies reinforces the genetic underpinnings, estimating of periodontitis at around 38% to 40%, with higher figures (up to 50%) for aggressive forms, indicating that shared explain a substantial portion of variance beyond environmental influences. These non-modifiable factors often interact with modifiable ones, such as , to further heighten severity.

Diagnosis

Clinical Examination

The clinical examination in periodontology involves a systematic, hands-on of the periodontal tissues to assess , extent, and progression , serving as the cornerstone for and treatment planning. This process typically begins with a of the gingiva for color, contour, and texture changes, followed by tactile assessments using calibrated instruments to quantify parameters. Key measurements focus on the depth and attachment status of periodontal pockets, inflammatory responses, and structural integrity of supporting tissues, enabling differentiation between and periodontitis. Central to the examination is periodontal probing, performed with a calibrated (typically 0.5 mm tip marked at 1-2 mm, 3 mm, 5 mm, 7 mm, and 10 mm intervals) inserted gently into the or pocket at a 60-degree angle to the surface. Probing depth (PD) is measured as the distance from the gingival margin to the base of the pocket, with normal sulci ranging from 1-3 mm; depths exceeding 4 mm suggest periodontal involvement. The clinical attachment level (CAL) is calculated as PD plus the distance of from the (CEJ), providing a measure of cumulative periodontal destruction; for example, a 5 mm PD with 2 mm recession yields a CAL of 7 mm. (BOP), recorded 30 seconds after insertion, indicates active , with prevalence rates above 25% signaling disease progression risk. Several validated indices quantify plaque accumulation and gingival during the examination. The Plaque Index (Silness-Löe), scored from 0 (no plaque) to 3 (abundant plaque) on the gingival third of surfaces, evaluates supragingival plaque thickness and correlates with gingival health. The Gingival Index (Löe-Silness), ranging from 0 (normal gingiva) to 3 (severe with ulceration), assesses qualitative changes in gingival color, consistency, and bleeding, based on examination of four surfaces per (mesial, distal, buccal, lingual). The Sulcus Bleeding Index, scored 0-5 (0 = no bleeding, 5 = immediate heavy bleeding) after 30 seconds of probing four sites per , specifically targets early detection by focusing on bleeding intensity. Tooth mobility is assessed by grasping the crown with two instruments (e.g., handles of explorers) and applying gentle buccolingual and vertical pressure, classified using the Miller system: grade 0 (none, physiologic <0.2 mm movement), grade I (<1 mm horizontal), grade II (>1 mm horizontal or any vertical), and grade III (movable in two directions, including vertical >1 mm or depressible in socket). This evaluates loss of periodontal support, with higher grades indicating advanced bone loss or trauma. Furcation involvement in multi-rooted teeth (molars, premolars) is probed horizontally at the furcation entrance using a curved Nabers probe, graded per Glickman: grade I (incipient, probe enters <3 mm with no interradicular bone loss), grade II (partial horizontal loss, probe passes but not through), and grade III (complete bone loss, probe passes interradicularly). Occlusal assessment includes evaluation of habits such as bruxism or clenching (parafunction), observed through tooth wear facets, fremitus (tooth movement during occlusion), and patient history of jaw pain or muscle tenderness, as these contribute to periodontal trauma. Extraoral components encompass palpation of submandibular and cervical lymph nodes for enlargement, tenderness, or induration, which may indicate systemic involvement or infection spread, and temporomandibular joint (TMJ) evaluation for clicks, crepitus, or pain on opening/closing to rule out confounding musculoskeletal issues. The standard protocol employs six-point charting per tooth (mesio-buccal, mid-buccal, disto-buccal, mesio-lingual, mid-lingual, disto-lingual), recording PD, CAL, BOP, and suppuration for all teeth in a full-mouth examination, typically completed in 10-15 minutes by a trained clinician using consistent force (approximately 0.25-0.75 N). This comprehensive approach ensures reproducible data for staging and grading periodontitis, with adjunctive radiographic confirmation used sparingly to validate clinical findings.

Radiographic and Adjunctive Assessments

Radiographic assessments play a crucial role in evaluating periodontal bone loss by visualizing alveolar bone levels and defect morphology. Periapical and bitewing radiographs are commonly employed to detect horizontal and vertical bone defects, offering a two-dimensional view of bone support around teeth. These images allow clinicians to identify crestal bone height and interproximal bone loss patterns, though they are limited in depicting buccal-lingual dimensions. Cone-beam computed tomography (CBCT) provides three-dimensional imaging essential for assessing furcation involvements and complex defects, with voxel resolutions typically ranging from 0.1 to 0.4 mm enabling precise visualization of bone architecture. Bone loss in periodontitis manifests in distinct patterns observable on radiographs. Horizontal bone loss appears as an even reduction in bone height parallel to the cemento-enamel junction (CEJ), representing the most common form in chronic periodontitis. Vertical or angular defects, often infrabony, present as oblique losses creating one-, two-, or three-walled pockets, which are better delineated on CBCT than conventional radiographs. These patterns correlate with clinical probing depths, aiding in the differentiation of disease progression. Adjunctive microbiological tests enhance diagnosis by identifying key pathogens. DNA probes, such as those used in checkerboard hybridization, detect the red complex bacteria—Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola—which are strongly associated with severe periodontitis. Host biomarker assays, including matrix metalloproteinase-8 (MMP-8) tests in gingival crevicular fluid or saliva, quantify collagen degradation activity with a sensitivity of approximately 83% for distinguishing active disease. Additional biomarkers like interleukin-1β (IL-1β) and receptor activator of nuclear factor kappa-B ligand (RANKL) indicate inflammatory activity and bone resorption, respectively, in gingival crevicular fluid or saliva. Chairside tests, such as PerioSafe, provide rapid point-of-care detection of active MMP-8 levels using oral rinse samples, facilitating immediate risk assessment. Despite their utility, radiographic methods have limitations. Two-dimensional radiographs suffer from distortion, superimposition, and magnification, potentially underestimating defect depth, while all expose patients to ionizing radiation, necessitating judicious use. CBCT, though superior for implant site evaluation and furcation assessment, delivers higher effective radiation doses compared to intraoral films. Recent advances as of 2025 include AI-assisted analysis of panoramic and CBCT radiographs, achieving staging accuracies exceeding 90% through automated segmentation of bone levels and cemento-enamel junctions. These models enhance diagnostic precision, particularly for general practitioners, with reported accuracies up to 98% in defect identification.

Treatment

Phase I: Initial Non-Surgical Therapy

Phase I initial non-surgical therapy represents the foundational step in periodontal treatment, focusing on disrupting the infectious biofilm and modulating the inflammatory response to arrest disease progression without invasive procedures. This phase emphasizes patient education and professional intervention to achieve supragingival and subgingival plaque control, typically spanning one to four visits depending on disease extent and patient factors. The primary goals are to reduce bacterial load through biofilm disruption, establish effective oral hygiene practices, control gingival inflammation, and assess the patient's response to therapy, ultimately aiming for pocket closure with probing depths ≤4 mm and no bleeding on probing. By eliminating supragingival plaque and subgingival calculus, this phase seeks to halt active periodontitis and create a stable environment conducive to healing. Procedures begin with comprehensive oral hygiene instruction, including the Bass technique for toothbrushing—placing the bristles at a 45-degree angle to the tooth surface with short vibratory strokes to access the gingival sulcus—and the use of interdental aids such as floss or interdental brushes to clean between teeth. Professional scaling and root planing follow, involving manual instruments like curettes or ultrasonic devices to remove deposits from root surfaces, often performed quadrant by quadrant or full-mouth in one session within 24 hours. These interventions, combined with reinforcement of self-care, form the core of mechanical plaque removal. Adjunctive therapies may enhance outcomes in select cases; chlorhexidine mouth rinses provide antimicrobial support during healing (Grade B evidence from 24 RCTs), while locally delivered agents like minocycline microspheres or chlorhexidine chips offer sustained release into pockets (weak recommendation with moderate net benefit). Systemic antibiotics, such as amoxicillin plus metronidazole, are reserved for necrotizing forms with systemic involvement like fever or lymphadenopathy, adjunctive to debridement. Lasers and photodynamic therapy are generally not recommended due to insufficient evidence of added benefit over standard care. Re-evaluation occurs 4-6 weeks post-therapy to measure reductions in probing depths and bleeding, expecting 50-70% pocket closure in responsive sites; persistent deep pockets (>5 mm with bleeding) indicate the need for further intervention. This phase is indicated for all patients with stage I-III periodontitis prior to any surgical consideration and as standalone treatment for mild cases with shallow pockets. It serves as a diagnostic tool to gauge disease reversibility through non-invasive means. Typical outcomes include 1-2 mm gains in clinical attachment level for moderate pockets (4-6 mm), with mean probing depth reductions of 1.7 mm overall and up to 2.6 mm in deeper sites (>6 mm), alongside 63-74% decreases in bleeding sites. Long-term stability, including reduced (0.09-0.15 teeth per year over 5-14 years), hinges on patient compliance with . If residual disease persists, this phase prepares the site for potential surgical approaches.

Phase II: Surgical Therapy

Phase II surgical therapy encompasses a range of procedures designed to access, eliminate, or regenerate periodontal structures in sites unresponsive to initial non-surgical interventions, thereby improving long-term periodontal health. These surgeries are typically indicated for persistent probing depths greater than 5 mm following Phase I therapy, furcation involvements that compromise , and esthetic concerns such as uneven gingival contours. Access flaps provide enhanced visibility and instrumentation of root surfaces while preserving gingival architecture. Full-thickness flaps are raised to expose the alveolar bone and roots for thorough in deeper defects. The modified Widman flap, involving an initial intracrevicular incision 0.5–1 mm from the gingival margin, a second horizontal incision at the alveolar crest, and removal of a gingival collar, facilitates meticulous root planing and promotes new attachment with minimal bone loss. This technique emphasizes atraumatic flap elevation and precise suturing to achieve close adaptation of the gingival margin to the , resulting in pocket depth reduction and epithelial reattachment. Resective procedures aim to eliminate pocket walls and recontour bone for a more maintainable , particularly in areas of horizontal bone loss. The apically positioned flap repositions the gingival tissue coronally to the bone crest using periosteal sutures, allowing access for and osseous . Osseous recontouring, or ostectomy and osteoplasty, removes irregularities to create a positive osseous form, with average bone resection of 0.6–1.2 mm per site; fiber retention variants minimize removal to about 0.4 mm while preserving supracrestal fibers. These approaches are suited for suprabony defects and posterior regions, achieving pocket elimination (probing depth ≤4 mm) in up to 98% of sites at 12 months and 95% closure without bleeding at 4 years. Regenerative techniques seek to restore lost periodontal tissues, including cementum, periodontal ligament, and alveolar bone. Guided tissue regeneration (GTR) employs non-resorbable expanded polytetrafluoroethylene (e-PTFE) membranes to exclude epithelial and connective tissue migration, creating a space for selective repopulation by periodontal cells; in advanced defects, this yields a 30.4% gain in mineralized tissue at 9–12 months post-re-entry. Enamel matrix derivatives, such as Emdogain, applied topically during flap surgery, mimic natural tooth development proteins to promote regeneration, resulting in an average 1.1 mm greater clinical attachment level gain and 0.9 mm pocket depth reduction compared to flap debridement alone at 1 year. Specific procedures address localized issues, including for gingival , where excess tissue is excised to reduce pocket depths and improve hygiene access in suprabony areas without extending below the mucogingival junction. involves complete removal of a restrictive frenum attachment to the , indicated for hypertrophic frenums causing gingival traction, , or interference with periodontal maintenance. Potential complications include , particularly with resective methods due to apical flap positioning, and postoperative infection, though the latter occurs at low rates of less than 1–4.4% without antibiotics. Overall success, defined by pocket closure and attachment stability, reaches 70–80% at 5 years for non-regenerative approaches, with higher survival rates exceeding 90% for treated teeth under rigorous .

Phase III: Restorative and Reconstructive Therapy

Phase III of periodontal therapy emphasizes the restoration of oral function, stability, and following the control of through initial and surgical phases. The primary goals include replacing missing teeth to maintain masticatory efficiency, stabilizing the occlusion to reduce forces on compromised periodontal structures, and enhancing esthetic outcomes to improve patient satisfaction and . This phase integrates with periodontal principles to ensure long-term periodontal health and prosthetic success. Key restorative procedures in this phase encompass crown lengthening, dental implants, fixed bridges, and removable partial dentures. Crown lengthening involves surgical recontouring of the gingival margin and, if necessary, alveolar bone to expose sufficient structure for proper crown placement, thereby preserving the biologic width and preventing restorative margins from encroaching on periodontal tissues. This procedure is indicated for subgingival caries, fractures, or short clinical crowns, with clinical outcomes showing stable periodontal health when performed adequately. Dental implants, particularly endosseous types, serve as a primary option for replacement, relying on —the direct structural and functional connection between the implant surface and living bone—which typically requires 3 to 6 months for completion before prosthetic loading. Fixed bridges and removable partial dentures provide alternative prosthetic solutions for edentulous spans, selected based on span length, occlusion demands, and patient factors, with success rates exceeding 90% over 5 years when supported by healthy . Reconstructive interventions focus on regenerating lost periodontal support to facilitate prosthetics. grafts, particularly subepithelial grafts harvested from the and placed with a coronally advanced flap, are employed for root coverage in defects, achieving complete root coverage in approximately 80% of cases and partial coverage in most others, with long-term stability up to 20 years when combined with proper plaque control. augmentation via guided regeneration (GBR) uses barrier membranes to exclude non-osteogenic cells while incorporating particulate autografts—harvested from intraoral sites like the or ramus—to promote alveolar reconstruction, yielding horizontal bone gains of 3 to 5 mm and vertical gains of 2 to 4 mm in preparation for placement. Autografts remain the gold standard for GBR due to their osteogenic, osteoinductive, and osteoconductive properties, with success rates over 85% in vertical defects when protected from loading. Occlusal therapy addresses mobility and traumatic forces through splinting and equilibration. Provisional splinting with fiber-reinforced composites or fixed prostheses connects mobile teeth to distribute occlusal loads, reducing mobility by up to 50% during and improving comfort, though long-term survival benefits in advanced periodontitis are limited without ongoing . Selective occlusal equilibration eliminates interferences and premature contacts to optimize force distribution, often resulting in improved clinical attachment levels around mobile teeth. A critical interface in Phase III is the requirement for periodontal clearance prior to definitive prosthetics, ensuring active resolution to minimize recurrence risks under prosthetic contours that may harbor plaque. This involves reevaluation of probing depths, attachment levels, and indices post-Phase II, with any residual addressed to achieve prosthetic exceeding 10 years. Multidisciplinary coordination is essential, integrating endodontic treatment for vital pulp preservation under restorations and orthodontic input for alignment adjustments to support occlusal stability.

Phase IV: Maintenance Therapy

Phase IV maintenance therapy, also known as supportive periodontal therapy (SPT), is a lifelong regimen designed to preserve periodontal following the completion of active treatment phases, preventing disease recurrence and supporting overall oral stability. It involves regular professional interventions tailored to the patient's individual risk profile, emphasizing surveillance and reinforcement of practices. This phase is essential for patients with a history of periodontitis, as it addresses residual risk factors and monitors for any signs of progression. The frequency of maintenance visits is typically scheduled every 3 to 6 months, with intervals personalized based on the patient's , including severity, compliance history, and modifiable factors like . For individuals with stable conditions and low risk, visits may extend to 6 months, while higher-risk cases require more frequent appointments, often quarterly, to minimize progression. According to EFP guidelines, supportive periodontal care visits range from 3 to 12 months, adjusted to the individual's likelihood of recurrence. Key components of maintenance therapy include professional supragingival and subgingival cleaning to remove plaque and , reinforcement of personalized instructions, and ongoing management of risk factors such as counseling and control. These sessions also involve updating medical and dental histories to identify any changes that could impact periodontal status. is integrated throughout, focusing on self-performed plaque control techniques and the importance of adherence to prevent accumulation. Monitoring during maintenance appointments entails re-evaluating clinical attachment levels (CAL) and (BOP) to detect early signs of or attachment loss, with radiographs recommended annually for high-risk patients to assess bone levels. These assessments guide adjustments to the care plan, ensuring timely intervention if needed. For patients with Stage III or IV periodontitis, protocols are more intensive, featuring visits every 3 months or less to accommodate greater susceptibility to progression, alongside enhanced on management and modifications. This approach prioritizes multidisciplinary coordination for complex cases involving or implant integration. Evidence from longitudinal studies demonstrates that regular maintenance therapy significantly reduces disease recurrence and by up to 70% in treated patients, underscoring its role in long-term success. It is particularly critical for dental implants, where SPT prevents by controlling and inflammation around restorations.

Professional Roles and Training

Periodontists

A periodontist is a who has specialized in the prevention, , and treatment of periodontal diseases, as well as the placement and of dental implants. These specialists focus on the —the tissues supporting the teeth, including the , alveolar , , and periodontal ligament—as well as related structures like implants and peri-implant tissues. The scope of practice for periodontists encompasses the comprehensive management of conditions such as gingivitis and periodontitis, ranging from initial diagnosis through advanced interventions. This includes non-surgical therapies like scaling and root planing, but extends prominently to surgical procedures such as flap surgery, bone grafting, guided tissue regeneration, and implant placement to restore periodontal health and function. Regenerative procedures, including the use of biomaterials to promote tissue regrowth, form a core part of their expertise, particularly in cases involving significant bone or soft tissue loss. In daily practice, periodontists primarily handle complex cases referred by general dentists, with a substantial portion of their work involving surgical expertise to address advanced or -related issues. They often participate in multidisciplinary teams, collaborating with restorative dentists, oral surgeons, and dental hygienists to optimize patient outcomes, such as coordinating integration with prosthetic rehabilitation. Consultations typically involve detailed assessments of progression and personalized treatment . Certification as a periodontist requires completion of an advanced residency program, after which professionals may pursue board eligibility and diplomate status through organizations like the American Board of Periodontology (ABP). The ABP certifies individuals who demonstrate in-depth knowledge and proficiency across the full scope of periodontology, including oral examinations and case presentations to validate clinical competence. Periodontists play a vital role in research, contributing to advancements in disease classification systems and innovative biomaterials. For instance, they have been instrumental in developing the 2017 World Workshop classification of periodontal and peri-implant diseases, which introduced staging and grading for more precise and . In biomaterials research, ongoing work includes stem cell-based therapies for periodontal regeneration, with 2024 studies highlighting their potential in enhancing and tissue repair through applications. Patient interactions for periodontists center on managing complex, high-risk cases where standard dental care is insufficient, such as severe periodontitis or . They develop long-term maintenance plans to prevent disease recurrence, educating patients on and monitoring progress through regular follow-ups.

Dental Hygienists and Therapists

Dental hygienists play a pivotal role in non-surgical periodontal , focusing on preventive measures and early intervention for mild to moderate . They conduct periodontal charting to assess pocket depths, , and attachment loss, which informs treatment planning and monitoring. This involves educating patients on techniques, such as proper brushing, flossing, and interdental cleaning, to empower self-management and prevent disease progression. Their includes performing Phase I initial non-surgical therapy, such as to remove plaque and calculus from tooth surfaces and below the gumline. Dental hygienists are authorized to expose and interpret radiographs for detecting bone loss and other periodontal issues, as well as conduct risk assessments evaluating factors like , , and genetic predispositions. In certain jurisdictions, such as many U.S. states, they can administer under direct supervision to facilitate comfortable scaling procedures. Training for dental hygienists typically requires an in dental hygiene, which typically takes two years and includes coursework in , , and periodontology, alongside clinical rotations emphasizing practices and periodontal charting. Programs integrate hands-on experience in non-surgical interventions and , preparing graduates to pass national and state licensing exams. in periodontal topics is often required to maintain licensure and stay updated on evidence-based practices. Dental hygienists collaborate closely with periodontists, operating under their supervision to deliver initial therapy and manage recall visits for ongoing . This partnership ensures seamless care transitions, with hygienists handling routine assessments and reinforcements while referring complex cases to specialists. Such teamwork supports comprehensive periodontal management without overlapping into surgical domains. Globally, variations exist in the roles of dental therapists, who often extend hygienist functions. In the , dually qualified hygienist-therapists provide advanced scaling, root planing, and periodontal maintenance for moderate disease, enhancing preventive outreach. In , oral health therapists perform similar non-surgical periodontal procedures, including risk assessments and , often in community settings to broaden access. These models integrate therapists into teams for efficient disease control. By managing preventive and non-surgical aspects, dental hygienists and therapists improve patient access to periodontal care, particularly in underserved areas, and help alleviate the workload on specialists through effective early interventions. This contributes to better overall oral health outcomes and reduced at the population level.

Training in the United States

To become a periodontist , candidates must first earn a Doctor of Dental Surgery (DDS) or Doctor of Dental Medicine (DMD) degree from a accredited by the Commission on Dental Accreditation (CODA). Following this, they pursue a postgraduate residency program in periodontology, which serves as the primary pathway to specialization. These residency programs typically last 36 months and are designed to provide comprehensive training in the diagnosis, prevention, and treatment of periodontal diseases, including implant dentistry. The curriculum balances clinical practice, didactic education, and research, with approximately 60% of the time dedicated to hands-on patient care, allowing residents to achieve competency in managing moderate to severe periodontitis (Stages II-IV) through nonsurgical and surgical interventions. Didactic components cover pathobiology of periodontal diseases, implantology, periodontal medicine, and evidence-based practices, often integrated with biomedical sciences such as microbiology and immunology. Residents must complete a research project or thesis as part of scholarly activity requirements, contributing to the scientific understanding of periodontology. During the program, trainees perform a substantial number of surgical procedures, typically exceeding 200 periodontal surgeries (excluding implants), to build proficiency in techniques like flap surgery and regenerative procedures. All periodontology residency programs must be accredited by CODA to ensure they meet national standards for advanced dental education, with 47 such programs available across U.S. dental schools as of 2024. Notable examples include programs at and the (UCLA) School of Dentistry, which emphasize both clinical excellence and interdisciplinary collaboration. Upon completing an accredited residency, graduates are eligible to take the certification examination administered by the American Board of Periodontology (ABP) to become a Diplomate, signifying advanced expertise in the field. The ABP exam consists of a written Qualifying Examination assessing knowledge in periodontology and an Oral Examination evaluating clinical judgment through case presentations and discussions. While not mandatory for practice, Diplomate status is widely recognized as a mark of professional distinction. After residency, many periodontists pursue optional fellowships to specialize further in areas such as esthetic dentistry or laser-assisted periodontal therapy, which provide advanced training in cosmetic gum procedures and minimally invasive techniques using or lasers. Recent CODA-accredited programs emphasize modules on dentistry and emerging digital technologies, reflecting updates in standards as of 2023, such as guided surgery and intraoral scanning for periodontal . These updates align with broader trends in precision dentistry while maintaining core standards similar to those in Canadian programs.

Training in Canada and Europe

In Canada, specialist training in periodontology is offered through three-year postgraduate programs that combine clinical training with a Master of Science (MSc) or Diploma in Periodontics, typically following a Doctor of Dental Surgery (DDS) degree. Prominent programs include those at the , , , , and , where residents manage complex periodontal cases, including those with medical comorbidities. These programs emphasize research, requiring a or equivalent project to foster and contributions to periodontal science. Upon completion, graduates are eligible for Fellowship certification by the Royal College of Dentists of Canada (RCDC), which assesses advanced clinical judgment, diagnostic reasoning, and communication through a two-day oral examination based on structured clinical cases. In , periodontology specialist training is standardized as a minimum three-year full-time postgraduate program, aligned with Directive 2005/36/EC for professional qualifications recognition and the European Federation of Periodontology (EFP) quality standards. EFP-accredited programs, offered at 24 institutions across countries including the , , , and , award degrees such as Master of Dental Science (MDSc) or Doctor of Clinical Dentistry (DClinDent) and total 180 European Credit Transfer System (ECTS) credits. The integrates didactic learning (e.g., basic sciences and evidence-based diagnosis), clinical practice in periodontal surgery and implantology, and research components, with residents treating multidisciplinary referred cases under supervision. In the , programs lead to eligibility for the General Dental Council (GDC) specialist list following national training pathways, while in , three-year programs at universities like and emphasize reconstructive therapy and implant dentistry. Certification in involves national boards and, for EFP-accredited graduates, a final examination comprising clinical case presentations and a research project defense to ensure proficiency. European programs often integrate periodontology more closely with compared to other regions, addressing systemic links in patient management. Some countries, like , maintain a consistent three-year duration, while others may extend to four years for part-time equivalents. In , the EFP updated its educational consensus to incorporate contemporary digital technologies, such as advanced and AI-assisted diagnostics, into periodontal training curricula. The 2025 EFP consensus on diagnostic technologies further integrates AI and advanced into training for enhanced clinical decision-making.

Prevention

Primary Prevention Strategies

Primary prevention of periodontal diseases focuses on strategies aimed at healthy individuals to inhibit the onset of conditions like and periodontitis, primarily through control and modification. These measures emphasize personal responsibility, community-level interventions, and professional guidance to maintain gingival health before disease develops. Effective primary prevention can significantly lower the incidence of early periodontal issues by promoting consistent habits and environmental supports that reduce plaque accumulation and . Personal oral hygiene forms the cornerstone of primary prevention, with recommendations for daily brushing twice for at least two minutes using fluoridated to remove plaque from surfaces. Interdental , such as flossing or using interdental brushes, is advised once daily to target areas between teeth where plaque buildup contributes to gingival irritation. education should begin around age 5, coinciding with school entry, to instill lifelong habits through supervised brushing and flossing techniques, as early intervention prevents the establishment of poor practices that lead to biofilm-related diseases. Community programs play a vital role in broad-scale prevention, including at 0.7 parts per million, which has been shown to reduce caries prevalence by approximately 25% in fluoridated populations and may contribute to improved periodontal health. School-based screenings and educational initiatives further support early detection and habit formation, targeting children to curb the progression from plaque to . Public health efforts, aligned with strategies, promote awareness of modifiable risks like poor and environmental factors through national campaigns and policy advocacy. Dietary and lifestyle modifications complement mechanical prevention, with emphasis on a balanced diet rich in nutrients that support gingival while limiting added sugars to minimize bacterial proliferation. Education on tobacco avoidance is critical, as reduces the risk of onset by impairing immune responses and vascular in the . Professional interventions include regular dental check-ups every 6 to 12 months for plaque removal and monitoring, along with the application of sealants on molars to prevent trapping and bacterial in fissures. Emerging public health tools, such as mobile apps for tracking routines, enhance adherence; by 2025, AI-powered oral health coaching apps provide reminders, technique feedback, and progress monitoring to reinforce daily practices. Clinical trials demonstrate that comprehensive interventions, including brushing and interdental aids, can reduce incidence by up to 40% over short-term periods, underscoring their efficacy in preventing disease initiation.

Secondary Prevention and Maintenance Protocols

Secondary prevention in periodontology encompasses strategies implemented after initial diagnosis and active treatment to halt disease progression, prevent recurrence, and maintain periodontal health in with a history of periodontitis. These protocols, often termed supportive periodontal care (SPC) or , focus on regular professional interventions tailored to individual risk profiles, emphasizing the removal of plaque and while reinforcing self-management to sustain treatment gains. This phase builds on Phase IV restorative and reconstructive by prioritizing long-term surveillance rather than acute interventions. Risk-based scheduling is a of secondary prevention, customizing recall intervals according to patient-specific factors such as status, , plaque control, and residual pocket depths to optimize outcomes and resource use. High-risk patients, including smokers who exhibit accelerated disease progression due to impaired and increased bacterial load, typically require recalls every 3 months to monitor and intervene early. In contrast, low-risk patients with stable periodontal status and effective may extend intervals to 12 months, as supported by evidence showing no increased progression risk in well-managed cases. This individualized approach, informed by the 2017 World Workshop classification system, enhances compliance and reduces unnecessary visits compared to fixed 3-month schedules, for which supporting evidence is limited. Core maintenance protocols involve professional supragingival and subgingival to eliminate and , combined with rinses to suppress and reinforcement of practices like proper brushing and flossing. Supragingival scaling targets coronal plaque, while subgingival addresses deposits in periodontal pockets, often using ultrasonic devices for efficiency in residual sites deeper than 4 mm. Adjunctive rinses, such as gluconate (0.12-0.2%), are recommended during and post-maintenance to reduce gingival , particularly in supportive care phases, with evidence from European Federation of Periodontology (EFP) guidelines indicating benefits in controlling recolonization without promoting resistance when used short-term. reinforcement includes personalized education on interdental aids and plaque-disclosing agents to empower patients, as poor correlates with recurrence rates up to 40% within 5 years. Behavioral strategies are integral to compliance, incorporating (MI) to address barriers like forgetfulness or low motivation, alongside monitoring tools and systemic condition management. MI, a patient-centered counseling technique, has demonstrated significant improvements in indices and reduced probing depths in periodontitis patients, with meta-analyses showing sustained benefits over 6-12 months when integrated into maintenance visits. Digital apps for tracking brushing frequency and appointment reminders, such as those linked to periodontal health platforms, aid compliance monitoring by providing real-time feedback, though adoption varies by patient demographics. For patients with , a key modifiable , maintenance protocols emphasize glycemic control (HbA1c <7%) through coordinated care, as poor control doubles periodontitis progression risk and undermines stability. Advanced adjunctive therapies include to modulate the oral and therapy for enhanced , though evidence for the latter remains mixed as of 2024. , such as Lactobacillus reuteri lozenges, administered post-, restore microbial balance by promoting beneficial bacteria and reducing pathogens like Porphyromonas gingivalis, with systematic reviews reporting 20-30% greater reductions in compared to scaling alone over 3-6 months. adjuncts, including diode or Er:YAG systems, aim to bactericidal effects and pocket reduction, but 2024 meta-analyses indicate inconsistent long-term benefits beyond mechanical therapy, with potential overtreatment risks outweighing gains in stable patients. These options are reserved for cases pending further randomized trials. For patients with dental implants, maintenance protocols adapt to peri-implant tissues, incorporating specific probing to assess mucosal without damaging the seal and periodic checks on prosthetic components to prevent loosening. Probing around implants, performed gently with probes at 6 sites per implant, evaluates and pocket depths (healthy <4 mm), as predicts peri-implantitis with 90% accuracy, higher than for natural teeth. checks, typically at 20-35 Ncm for abutment screws, occur every 6-12 months to detect mobility early, alongside radiographic monitoring for bone loss, ensuring implant survival rates exceed 95% at 5 years with adherence. Long-term outcomes underscore the efficacy of adherent secondary prevention, with studies reporting approximately 80% of patients maintaining periodontal stability—no further attachment loss or —over 5 years when following risk-based protocols. Non-adherent patients experience 3-4 times higher rates (0.2-0.4 teeth/year), highlighting compliance as the primary determinant of success. These findings, derived from prospective cohorts, affirm that consistent preserves and , with stability persisting beyond 10 years in low-risk adherent groups.

References

Add your contribution
Related Hubs
User Avatar
No comments yet.